University of Wisconsin Milwaukee

UWM Digital Commons
Theses and Dissertations

August 2014

Memory Retrieval Is Maintained By Intrinsic and
Synaptic Plasticity in Prelimbic Cortex
James Otis
University of Wisconsin-Milwaukee

Follow this and additional works at: https://dc.uwm.edu/etd
Part of the Neuroscience and Neurobiology Commons, Psychiatric and Mental Health
Commons, and the Psychology Commons
Recommended Citation
Otis, James, "Memory Retrieval Is Maintained By Intrinsic and Synaptic Plasticity in Prelimbic Cortex" (2014). Theses and
Dissertations. 744.
https://dc.uwm.edu/etd/744

This Dissertation is brought to you for free and open access by UWM Digital Commons. It has been accepted for inclusion in Theses and Dissertations
by an authorized administrator of UWM Digital Commons. For more information, please contact open-access@uwm.edu.

MEMORY RETRIEVAL IS MAINTAINED BY INTRINSIC AND
SYNAPTIC PLASTICITY IN PRELIMBIC CORTEX

by

James M. Otis

A Dissertation Submitted in
Partial Fulfillment of the
Requirements for the Degree of

Doctor of Philosophy
in Psychology

at
The University of Wisconsin-Milwaukee
August 2014

ABSTRACT

MEMORY RETRIEVAL IS MAINTAINED BY INTRINSIC AND
SYNAPTIC PLASTICITY IN PRELIMBIC CORTEX

by

James M. Otis

The University of Wisconsin-Milwaukee, 2014
Under the Supervision of Devin Mueller

Abnormally strong memories underlie common disorders including addiction and posttraumatic stress disorder (PTSD). Memory disruption would therefore be beneficial for
treatment of these disorders. Evidence reveals that cocaine conditioned place preference
(CPP) memories are susceptible to long-lasting disruption during memory retrieval. For
example, inhibition of β-adrenergic receptor (β-AR) activity within the prelimbic medial
prefrontal cortex (PL-mPFC) prevents cocaine CPP memory retrieval, and this retrieval
impairment is both long-lasting and prevents subsequent reinstatement of the CPP.
Despite this, whether PL-mPFC β-AR activity is a fundamental mechanism required to
maintain retrieval of other memories is unclear. Furthermore, how PL-mPFC β-AR
activity maintains memory retrieval is unknown. Thus, here I use a combination of
behavioral and electrophysiological techniques to 1) evaluate how PL-mPFC β-AR
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activity regulates retrieval of memories related to a natural reward and to an aversive
stimulus and 2) to determine the mechanism of memory retrieval deficits.
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Introduction
Potentially rewarding or threatening stimuli are particularly relevant to an
organism. Presentation of these stimuli augments arousal and attention, and ensuing
improvement of sensory perception, learning, and memory allows fast and accurate
responses to a potential reward or threat (Sara and Bouret, 2012). Although this increases
the likelihood of survival within an environment, stimulus-induced enhancement of
learning and memory can also become problematic.
Pathological forms of memory drive inappropriate behaviors that are destructive
to normal health and behavior. Disruption of these memories would therefore be
beneficial for treatment of memory-related psychiatric diseases. Here, I use drug
addiction and post-traumatic stress disorder (PTSD) as model diseases to describe how
pathological forms of memory can lead to disordered behaviors. Moreover, research
regarding memory disruption, particularly by β-adrenergic receptor (β-AR) blockade
during memory retrieval, is described. The mechanisms by which β-AR blockade
disrupts memory retrieval are not known. Thus, a series of experiments were performed
using a combination of behavioral and electrophysiological techniques to 1) determine
the mechanism of memory retrieval impairments and 2) evaluate whether β-AR activity
during memory retrieval is a fundamental mechanism required for the maintenance of
memories.

Natural and pathological appetitive learning
Survival and reproduction depend on obtaining rewards such as food, shelter, and
sex. To obtain these rewards efficiently an organism must learn based on previous
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experiences. For example, environmental stimuli become associated with a reward as
positively reinforced behaviors are completed (Pavlov, 1927). Following this learning,
presentation of reward-related cues can motivate behaviors which have previously been
reinforced by that reward (Hyman, 2005). Unfortunately, stimulus-reward learning can
become too strong, leading to pathological forms of appetitive memory.
Drug abuse induces the formation of strong associations between environmental
stimuli and drug effects. Presentation of drug-associated cues can subsequently provoke
abnormal autonomic responses and subjective reports of craving among addicts
(Childress et al., 1986a, b; Ehrman et al., 1992), and these cravings drive compulsive
drug seeking (Herman, 1974; O'Brien et al., 1991). Unfortunately, compulsive drug
seeking can persist despite negative consequences (e.g., withdrawal, illness, anxiety, and
intoxication) and this behavior can supplant healthy, positively reinforcing behaviors.
However, disruption of drug-associated memories would prevent cue-induced drug
seeking, limiting relapse susceptibility.

Natural and pathological fear learning
Survival also depends on learning to avoid and escape danger. Stimuli that are
coupled with a perceived threat, such as the howl of a predator, become associated with
the danger. Following this learning, presentation of the threat-associated stimuli can
drive the behaviors that promote avoidance of the threatening stimulus. However, fear
learning can also become problematic.
Traumatic experiences, such as combat or a violent assault, can lead to PTSD.
This disorder develops gradually following a trauma, and initial symptoms include
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cognitively re-experiencing the event even with attempts to avoid such thoughts (Grillon
et al., 1996). This leads to a pathological form of memory, in which cues associated with
the event are particularly capable of reminding the patient of the trauma. Thus,
presentation of trauma-related cues (e.g., a noise) can induce an exaggerated fear
response, which may include startle, perspiration, shortness of breath, and panic.
However, disruption of traumatic memories would be beneficial for treatment of PTSD
(Pitman et al., 2002; Brunet et al., 2008).

Memory acquisition, consolidation, retrieval, and reconsolidation
Appetitive and aversive learning require overlapping neural mechanisms (Peters
et al., 2009). Research reveals that formation and expression of these memories occurs in
several stages, including acquisition, consolidation, retrieval, and reconsolidation (Abel
and Lattal, 2001; Nader and Hardt, 2009). First, memory acquisition is the earliest stage
of learning, during which an association exists as a short-term memory. Second, memory
consolidation is the process by which a short-term memory becomes long-term. Third,
memory retrieval is the reactivation of a consolidated memory, allowing memory recall
and/or behavioral expression of the memory. Therefore, consolidated memories are not
functional if memory retrieval is disrupted. Last, memory reconsolidation is the process
by which a retrieved memory becomes labile and is again consolidated into long-term
storage. Reconsolidation likely reflects “memory updating”, and recent research reveals
that many types of memories are susceptible to disruption during this process (Nader and
Hardt, 2009). Thus, memory retrieval and reconsolidation are of particular importance to
disorders associated with pathological forms of memory, as disruption of these processes
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could prevent cue-induced behaviors. To understand the mechanisms required for
retrieval and reconsolidation, neuroscientists use rodent memory models. Next, I focus
on three rodent models that are used to study memory.

Conditioned place preference
The conditioned place preference (CPP) paradigm is commonly used to
investigate the neural mechanisms of drug-associated memories. In this paradigm, rats
are trained to associate one chamber, but not another, with a drug of abuse. Following
training, all rats are given full access to both chambers while in a drug-free state. During
these CPP trials more time is spent within the drug-paired chamber than within the salinepaired chamber. Thus, a CPP for the previously drug-paired chamber is expressed.
When a CPP is expressed investigators can be certain that animals acquired, consolidated,
and retrieved the drug-associated memory. Moreover, the mechanisms underlying these
processes can be investigated through pharmacological manipulation at different time
points throughout CPP experiments. For example, the mechanisms underlying drugassociated memory retrieval can be examined via pharmacological manipulation before a
drug-free CPP trial. The effects of such manipulation can be determined by assessing
CPP expression during the CPP trial. In contrast, memory reconsolidation can be studied
by manipulating the rodents immediately after a retrieval trial. The effects of that
manipulation can then be assessed during another CPP trial the following day. Thus, the
CPP procedure allows for the investigation of drug-associated memory retrieval and
reconsolidation.
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Self-administration
The self-administration paradigm is seldom used to study drug-associated
memories, possibly due to confusion regarding the proper methods required to investigate
memory within this model. In the self-administration paradigm, rats learn to press a lever
for an intravenous infusion of a drug. Moreover, drug infusions are paired with cues that
become associated with drug availability. Drug self-administration training takes a series
of days to weeks, such that the behavior becomes well-rehearsed and probably habitual.
Consistent with this idea, even limited cocaine self-administration can cause insensitivity
to devaluation of cocaine, indicating that self-administration becomes a behavior that is
not goal-oriented (Zapata et al., 2010). Moreover, this habitual cocaine seeking is
blocked by inactivation of the dorsal striatum, a structure that is critical for habit learning
(Zapata et al., 2010). In contrast, goal-oriented cocaine seeking is not blocked by dorsal
striatum inactivation (Zapata et al., 2010). Thus, drug self-administration becomes a
habitual behavior, and likely depends on neural circuits responsible for habit learning, but
not memory retrieval.
Consistent with the idea that self-administration becomes a habitual behavior;
data suggest that self-administration becomes independent of brain structures that are
critical for memory retrieval, particularly the prelimbic medial prefrontal cortex (PLmPFC). PL-mPFC is critical for memory retrieval (Corcoran and Quirk, 2007; Peters et
al., 2009; Otis et al., 2013), and PL-mPFC activation is necessary for acquisition of an
operant response before an action becomes habitual (Killcross and Coutureau, 2003;
Ostlund and Balleine, 2005). Thus, drug self-administration may become independent of
PL-mPFC during training. Indeed, inactivation of the PL-mPFC prevents the acquisition
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of self-administration, but has no effect directly after self-administration training (Di
Ciano et al., 2007). Thus, drug self-administration becomes 1) habitual and dependent on
neural circuits responsible for habit learning and 2) independent of goals and independent
of neural circuits responsible for memory retrieval. Importantly, extinction learning is
likely to reverse this distinction, such that drug self-administration becomes dependent on
memory retrieval.
Following drug self-administration training, rats undergo extinction during which
lever presses do not lead to drug infusions. To study memory retrieval, extinction must
occur in the absence of drug-associated cues or within an alternative context. This allows
for extinction of the habitual behavior (lever pressing), but not extinction of the drug-cue
or drug-context memories. Following successful extinction training, rats no longer press
the lever for the drug. However, drug seeking can be reinstated upon re-presentation of
the drug-associated cue or context. As drug seeking at this time is no longer habitual, cue
or context-induced reinstatement is likely to require memory retrieval. In support of this,
many studies reveal that cue-induced and context-induced reinstatement of drug selfadministration is PL-mPFC dependent (Capriles et al., 2003; McLaughlin and See, 2003;
Fuchs et al., 2005; Ball and Slane, 2012). Thus, cue-induced reinstatement and contextinduced reinstatement allow for investigation memory retrieval within the selfadministration paradigm.
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Fear conditioning
Fear conditioning is a commonly used model of aversive learning and memory.
In this paradigm, rats are trained to associate a conditional stimulus (CS), such as a
context or an auditory tone, with an aversive unconditional stimulus (UCS), such as a
foot shock. Along with context fear conditioning, two distinct types of cued fear
conditioning are commonly used. First, delay fear conditioning involves the presentation
of a CS that terminates with the UCS. Second, trace fear conditioning involves the
presentation of the CS and UCS, but these stimuli are separated in time by a silent ‘trace
interval’. Thus, trace fear learning is slightly more complex and requires more neural
processing, such as PL-mPFC activation during the trace interval (Runyan et al., 2004;
Gilmartin and McEchron, 2005; Gilmartin and Helmstetter, 2010; Gilmartin et al., 2013).
Following context, delay, or trace fear conditioning rats are tested via presentation of the
CS (context or discrete cue) in the absence of the UCS during fear memory retrieval tests.
During this test, presentation of the CS induces a conditional response (CR), such as a
rise in heart rate, blood pressure, and/or freezing of movement. If rats express a CR
following presentation of the CS, investigators can conclude that the animals acquired,
consolidated, and retrieved the fear-associated memory. Similar to place conditioning,
the mechanisms underlying fear memory retrieval can be studied via manipulations
before a CS test, whereas the mechanisms underlying reconsolidation can be studied via
manipulations after a CS test.
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Memory retrieval and noradrenergic signaling
Memory retrieval can be operationally defined as the neural process by which a
consolidated memory is reactivated. Retrieval allows for conscious recollection and
behavioral expression of memory. It is important to note that investigations of memory
retrieval in rodents actually use behavioral expression to make inferences regarding
memory retrieval. Although impairments in memory retrieval would prevent behavioral
expression of the memory, behavioral expression can also be disrupted by influencing
nonspecific factors such as motor activity, motivation, and attention. Thus, researchers
should be careful with interpretations when investigating memory retrieval. Moreover,
when making conclusions regarding memory retrieval it is critical to run experiments that
control for nonspecific effects of the manipulations on behavioral expression of memory.
The neural mechanisms underlying memory retrieval are not well understood.
Early studies revealed that behavioral expression of memories can be enhanced by
cocaine (Rodriguez et al., 1993), amphetamine (Sara and Deweer, 1982), and nicotine
(Faiman et al., 1992). These drugs are nonspecific, although each is capable of
enhancing noradrenergic signaling. More specific agonists of noradrenergic signaling
have also been given during a retrieval test in the memory forgetfulness task. In this
paradigm, rats learn and over time forget a path which will guide them to the end of a
maze. Enhancement of noradrenergic signaling, via inhibition of α2-adrenergic
autoreceptors which inhibit norepinephrine release, enhances behavioral performance in
the maze after forgetting (Sara and Devauges, 1989). Similarly, stimulation of the locus
coeruleus (LC), a major nucleus of noradrenergic cell bodies (Dahlstroem and Fuxe,
1964), also enhances memory expression in this task (Sara and Devauges, 1988). Finally,
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the enhancement of memory expression by LC stimulation is prevented by the βadrenergic receptor (β-AR) antagonist propranolol (Devauges and Sara, 1991). Taken
together, these studies indicate that memory retrieval may be enhanced by stimulation of
noradrenergic signaling, and that this effect is dependent on β-AR activation.
Stimulation of noradrenergic signaling enhances memory expression, although it
was unclear whether noradrenergic signaling is necessary for memory retrieval.
Murchison and colleagues (2004) addressed this issue by using mice which lack
dopamine β-hydroxylase (DBH), a necessary enzyme for norepinephrine and epinephrine
synthesis from dopamine. DBH knockout mice expressed fear during the learning phase
of a contextual fear task but were unable to express this memory 1 to 4 days later.
Similar results were also found in the Morris water maze, another spatial memory
paradigm. Interestingly, memory expression for DBH knockout mice was intact in a
variety of discrete cue-induced memory tasks. Furthermore, wild-type mice treated with
β-AR antagonists expressed less fear during a contexual retrieval test, whereas mice
treated with β-AR agonists expressed more fear during a contextual retrieval test
(Murchison et al., 2004). Interestingly, these effects were not present in a variety of
discrete cued tasks, allowing the researchers to control for nonspecific effects of the
manipulations on behavioral expression of the memory. Thus, these data demonstrated
that retrieval of contextual memories is dependent on β-AR signaling.
Although the evidence described indicates that β-AR signaling mediates retrieval
of contextual, but not discrete cued memories, other evidence is at odds with this
distinction. For example, systemic injections of propranolol, a β-AR antagonist, reduces
cue-induced fear expression in rats (Rodriguez-Romaguera et al., 2009). Moreover,
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propranolol reduces the firing rate of prelimbic medial prefrontal cortex (PL-mPFC)
neurons in vivo (Rodriguez-Romaguera et al., 2009), a structure that is necessary for
expression of fear memories (Corcoran and Quirk, 2007). Thus, whether β-AR activation
is required for both context and discrete cue-induced memory retrieval remains unclear.

Persistent retrieval impairments in humans and rodents
Despite evidence supporting β-AR involvement in retrieval, only a few studies
have examined whether this activity is required to successfully maintain future memory
retrieval. Recent data reveals that propranolol disrupts recall of visual memories and
emotional words in humans (Kroes et al, 2010; Kroes et al, 2012 SfN Abstracts) and
heroin-related words in human heroin addicts (Zhao et al., 2010). Moreover, the effects
of β-AR blockade on memory recall in humans are long lasting (Kroes et al., 2010), and
may prevent memory reinstatement (Kroes et al, 2012 SfN Abstracts). Although these
findings are somewhat surprising given current models of memory, recent data support
the conclusion that memory retrieval can be persistently impaired by β-AR blockade.
We recently investigated the effects of β-AR blockade on drug-associated
memory retrieval in rodents. Using a cocaine-induced CPP paradigm, we found that
systemic injections (Otis and Mueller, 2011), PL-mPFC microinfusions (Otis et al.,
2013), or dorsal hippocampus (dHipp) microinfusions (Otis et al., 2014a) of β-AR
antagonists prevents CPP memory expression. Similar to human studies, the effects of βAR blockade on CPP expression persisted during subsequent days in the absence of
further propranolol treatment. Moreover, these memory impairments prevented
subsequent cocaine-induced reinstatement of a CPP (Otis and Mueller, 2011; Otis et al.,
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2014a). Below, I thoroughly describe these data and associated control studies which led
to the conclusion that CPP memory retrieval can be persistently impaired by β-AR
blockade during retrieval.
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Otis and Mueller, 2011
We first investigated the necessity of β-AR activation for cocaine-associated CPP
memory retrieval. Rats were conditioned to associate one chamber with cocaine (10
mg/kg or 20 mg/kg) and another with saline before daily CPP tests. Moreover, rats were
given systemic injections of saline or the β-AR antagonist propranolol before the first
CPP test only. Rats treated with saline expressed a CPP for the previously cocaineassociated chamber during the first CPP test and during all subsequent tests overall,
whereas rats treated with propranolol did not (see Figure 1A and Figure 1B). We next
replicated these findings, but rats were injected with saline or propranolol before the
second CPP test. All rats expressed a CPP during the first injection-free test. Moreover,
rats treated with saline expressed a CPP for the previously cocaine-associated chamber
during the second CPP test and during subsequent injection-free trials overall. In
contrast, rats treated with propranolol did not express a CPP during the second test or
during subsequent propranolol-free tests (see Figure 2). We again replicated these
findings but injected rats with saline or propranolol before the second, third, and fourth
CPP tests. All rats expressed a CPP during the first injection-free test. Moreover, rats
treated with saline expressed a CPP during all subsequent CPP tests overall, including an
injection-free CPP test 2 weeks later. However, propranolol-treated rats did not express a
CPP during these tests or during the injection-free test 2 weeks later (see Figure 3). Thus,
systemic administration of propranolol before the first or second CPP test prevented the
expression of a cocaine-induced CPP memory, and this effect persisted for a minimum of
2 weeks.
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Multiple unreinforced CPP tests lead to extinction learning, resulting in no CPP
expression during subsequent tests. Following extinction, reinstatement of a CPP can be
induced via administration of cocaine (Mueller and Stewart, 2000). Thus, we determined
whether the persistent CPP expression deficit prevented cocaine-induced reinstatement of
the CPP. Following conditioning, rats were treated with saline or propranolol before the
second, third, and fourth CPP tests. Behaviorally, both extinction learning and
propranolol treatment abolish CPP expression. Thus, rats treated with saline received an
extra 8 CPP extinction tests of longer duration (30 minutes) to ensure extinction of the
CPP. During the final CPP test, neither saline- nor propranolol-treated rats expressed a
CPP. The following day, rats previously treated with saline expressed cocaine-induced
reinstatement of the CPP, whereas rats previously treated with propranolol did not (see
Figure 4). Thus, previous treatment with propranolol provided long-lasting protection
against cocaine-induced reinstatement of the CPP.
Propranolol has effects on both the central and peripheral nervous systems (Street
et al., 1979), and therefore the effects of propranolol on CPP expression could be due to
β-AR blockade in either system. To investigate this, we administered sotalol, a
peripheral β-AR antagonist that does not cross the blood-brain barrier (Dahlof, 1981),
before the second, third, and fourth CPP tests. Rats treated with saline and sotalol
expressed a CPP during the first CPP test and during subsequent tests overall (see Figure
5). Thus, sotalol did not prevent CPP memory expression, indicating that the effects of
propranolol are due to β-AR blockade in the central nervous system.
Propranolol has effects that are not specific to β-AR blockade when administered
at high doses, including protein kinase C inhibition and serotonergic receptor blockade

14

(Alexander and Wood, 1987; Sozzani et al., 1992). Thus, we examined the effect of a
low dose of (-)-propranolol (1 mg/kg), the more active enantiomer which is more
selective for β-ARs. Following conditioning, rats were given systemic injections of saline
or (-)-propranolol before the first CPP test. Rats treated with saline expressed a CPP for
the previously cocaine-associated chamber during the first CPP test and during all
subsequent tests overall, whereas rats treated with (-)-propranolol did not (see Figure
6A). Thus, a low dose of (-)-propranolol induced a persistent disruption of CPP
expression, supporting the conclusion that the effects of propranolol on CPP expression
are specific to β-AR blockade.
Propranolol and other β-AR antagonists are capable of preventing CPP memory
reconsolidation (Bernardi et al., 2006; Fricks-Gleason and Marshall, 2008; Bernardi et
al., 2009). Thus, the persistent effects of propranolol on CPP expression could be
attributable to reconsolidation blockade. To investigate this, following conditioning rats
were given systemic injections of saline or propranolol immediately before, instead of 20
minutes before the first CPP test. In this case, propranolol is unlikely to have effects until
after the CPP trial, during memory reconsolidation and after a CPP has already been
expressed. Rats treated with propranolol expressed a CPP for the previously cocaineassociated chamber during the first CPP test and during subsequent CPP trials overall
(see Figure 6B). Thus, propranolol administration immediately before a CPP test did not
prevent subsequent CPP expression. Taken together, these data reveal that propranolol
persistently impairs CPP expression without having effects on memory reconsolidation.
We also examined whether propranolol induced an affective state capable of
altering CPP expression, or if propranolol altered locomotor activity. Rats were
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conditioned to associate one chamber with propranolol and another with saline.
Following conditioning, rats were given a CPP test during which no CPP or aversion was
expressed for the previously propranolol-paired chamber (see Figure 6C). Thus,
propranolol itself does not induce an affective state capable of influencing CPP
expression. Finally, we determined the effects of propranolol on locomotor activity by
measuring the number of photobeam breaks during a CPP trial. Rats treated with saline
and propranolol had equivalent photobeam breaks during the CPP trial, indicating that
propranolol did not influence locomotor activity (see Figure 6D). Taken together, the
effects of propranolol are not attributable to reconsolidation blockade or other
nonspecific effects on behavioral expression of the memory. Thus, β-AR blockade
persistently impairs CPP memory retrieval, and this provides protection against
subsequent cocaine-induced reinstatement.
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Figures: Otis and Mueller, 2011
Figure 1

Figure 1. β-AR blockade persistently impairs cocaine CPP memory expression.
Following conditioning with (A) 10 mg/kg or (B) 20 mg/kg of cocaine, systemic
injections of propranolol, but not saline, before the first CPP trial prevented rats from
expressing a cocaine CPP. Rats previously treated with propranolol, but not saline,
continued to express no cocaine CPP during subsequent propranolol-free trials (Otis and
Mueller, 2011). ***p < 0.001, **p < 0.01, and *p < 0.05.
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Figure 2

Figure 2. β-AR blockade persistently impairs cocaine CPP memory expression when
administered before the second CPP trial. Following conditioning, systemic injections of
propranolol, but not saline, before the second CPP trial persistently impair CPP
expression (Otis and Mueller, 2011). ***p < 0.001 and *p < 0.05.
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Figure 3

Figure 3. Effects of β-AR blockade on CPP expression are long-lasting. (A) Systemic
injections of propranolol, but not saline, before the second, third, and fourth CPP trials
persistently impair CPP expression. (B) Rats previously treated with propranolol, but not
saline, continued to express no CPP following a 14-day break from testing (Otis and
Mueller, 2011). ***p < 0.001, **p < 0.01, and *p < 0.05.
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Figure 4

Figure 4. Effects of β-AR blockade on CPP expression prevent subsequent cocaineinduced reinstatement. Rats treated with saline or propranolol expressed no CPP during
the final CPP extinction trial. Rats previously treated with saline, but not propranolol,
expressed cocaine-induced reinstatement of the CPP (Otis and Mueller, 2011). Sal,
saline; Prop, propranolol; **p < 0.01.
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Figure 5

Figure 5. Peripheral β-AR blockade has no effect on CPP expression. Rats treated with
sotalol did not prevent CPP expression across trials (Otis and Mueller, 2011). ***p <
0.001, **p < 0.01, and *p < 0.05.
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Figure 6

Figure 6. Effects of systemic propranolol injections on CPP expression are not due to
nonspecific effects. (A) Systemic injections of (-)-propranolol, but not saline, induced a
persistent deficit in CPP expression. (B) Systemic injections of propranolol immediately
before a CPP trial did not completely prevent subsequent CPP expression. (C) Rats spent
an equivalent amount of time within previously propranolol-paired and saline-paired
chambers. (D) Systemic injections of propranolol did not affect locomotor activity, as
measured by photobeam breaks during a CPP trial (Otis and Mueller, 2011). ***p <
0.001 and **p < 0.01.

22

Neurobiological mechanisms of memory retrieval
The above results indicate that retrieval is dependent on β-AR activation in the
central nervous system. Our next goal was to determine the locus at which β-AR
activation is required for retrieval. We focused on three structures that are known to be
important for the expression of learned behaviors: PL-mPFC, basolateral amygdala
(BLA), and dHipp.

PL-mPFC involvement in memory retrieval
The PL-mPFC is necessary for the expression of learned fear. Unit recordings in
rats reveal that PL-mPFC pyramidal neurons become active during presentation of a CS
that was previously paired with an aversive US (Burgos-Robles et al., 2009; SotresBayon et al., 2012). This activity likely drives fear expression, as electrical stimulation
of PL-mPFC augments cue-induced fear (Vidal-Gonzalez et al., 2006). In contrast,
inactivation of PL-mPFC prevents cue and context-induced fear expression, whereas PLmPFC inactivation does not prevent innate fear of a predator or fear of open spaces
(Corcoran and Quirk, 2007). Thus, PL-mPFC activity is involved in expression of
learned, but not innate fear. This dissociation allows for the conclusion that PL-mPFC
activation is necessary for retrieval, not only behavioral expression, of fear memories.
PL-mPFC activity may also been critical for drug-associated memory retrieval.
Exposure to a previously cocaine-paired cues leads to robust PL-mPFC immediate early
gene expression (Miller and Marshall, 2004, 2005; Zavala et al., 2008) indicating that
presentation of a cocaine-associated context may activate PL-mPFC. Furthermore, druginduced CPP expression is blocked by PL-mPFC lesions (Isaac et al., 1989; Tzschentke
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and Schmidt, 1999) or PL-mPFC DNA-methyltransferase inhibition (Han et al., 2010).
Thus, expression of a drug-associated CPP memory depends on PL-mPFC activity.
PL-mPFC also regulates cue-induced drug seeking within the drug selfadministration paradigm. Pharmacological inactivation of the PL-mPFC prevents cue
and context-induced reinstatement of self-administration (McLaughlin and See, 2003;
Fuchs et al., 2005; Hiranita et al., 2006; Ball and Slane, 2012). Taken together, PLmPFC is important for behavioral expression of fear and drug-associated memories.

BLA involvement in memory retrieval
The PL-mPFC has reciprocal connections with the basolateral amygdala (BLA)
(Ishikawa and Nakamura, 2003; Gabbott et al., 2005), and BLA acts as a sensory
interface for expression of learned fear (LeDoux, 2000). Sensory inputs converge within
BLA (LeDoux et al., 1990b; LeDoux et al., 1990a; Romanski et al., 1993) , and BLA
neurons spike upon presentation of a shock-associated CS (CS+), but not upon
presentation of a neutral CS (Quirk et al., 1995; Quirk et al., 1997). Furthermore,
disruption of BLA activity prevents cue-induced fear expression (Kim et al., 1993; Maren
et al., 1996a; Lee et al., 2001). Taken together, sensory inputs to the BLA allow cueinduced fear expression. BLA also receives input from the hippocampus (Canteras and
Swanson, 1992), and this pathway may provide contextual information for fear
expression (LeDoux, 2000). In support of this, context-induced fear expression is
dependent on BLA and dHipp activity (Kim and Fanselow, 1992; Phillips and LeDoux,
1992; Helmstetter and Bellgowan, 1994; Maren et al., 1996b; Maren et al., 1997). Thus,
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BLA receives input regarding sensory and contextual information for the expression of
learned fear.
The BLA is also important for the expression of drug-associated memories.
Exposure to a previously cocaine-paired environment leads to robust BLA immediate
early gene expression (Miller and Marshall, 2004, 2005). Moreover, human studies
reveal that drug-associated cue exposure increases amygdalar metabolic activity, and this
activity correlates with reported drug cravings (Grant et al., 1996). BLA lesions or
inactivation prevent drug-induced CPP expression (Hiroi and White, 1991; Brown and
Fibiger, 1993; McDonald et al., 2010) and sucrose-induced CPP expression (Everitt et al.,
1991). Inactivation of the BLA protein kinase C (PKC) and protein synthesis also
transiently impairs CPP expression (Lai et al., 2008). In contrast, inhibition of BLA
PKA, which is downstream of β-ARs (Pedarzani and Storm, 1993; Raman et al., 1996)
has no effect on cocaine CPP expression (Lai et al., 2008). Taken together, although the
BLA is critical for drug-induced CPP expression, BLA β-AR dependent signaling is
unlikely to mediate drug-induced CPP expression.
Evidence reveals that BLA activity is critical for retrieval of drug-associated selfadministration memories. Exposure to cues associated with cocaine self-administration
induces expression of BLA immediate early genes (Neisewander et al., 2000). Moreover,
BLA lesions or pharmacological inactivation prevent cue-induced reinstatement of drug
seeking (Meil and See, 1997; Grimm and See, 2000; Fuchs and See, 2002; Kantak et al.,
2002; Yun and Fields, 2003; Fuchs et al., 2005). In contrast, BLA inactivation has no
effect on cocaine-induced reinstatement of cocaine seeking (Grimm and See, 2000).
These data reveal that BLA activation is necessary for expression of cue-induced cocaine
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seeking, and not simply expression of cocaine seeking. Thus, the conclusion can be
made that BLA activity is critical for retrieval of drug-associated memories in the selfadministration paradigm.

dHipp involvement in memory retrieval
The dorsal hippocampus (dHipp) has reciprocal connections with PL-mPFC
through its ventral subregion (vHipp) and through the nucleus reuniens of the thalamus
(Hoover and Vertes, 2007; Vertes et al., 2007). Moreover, the dHipp regulates
expression of contextual fear memories. Lesions or pharmacological inactivation of the
dHipp prevents context-induced fear (Kim and Fanselow, 1992; Phillips and LeDoux,
1992; Maren and Fanselow, 1997; Holt and Maren, 1999; Corcoran and Maren, 2001). In
contrast, dHipp lesions or inactivation do not impair discrete cue-induced fear (Kim and
Fanselow, 1992; Corcoran and Maren, 2001). Consistent with this, pharmacological or
genetic disruption of dHipp β-AR signaling abolishes context, but not discrete cueinduced fear expression (Murchison et al., 2004). These data reveal that dHipp β-AR
signaling is necessary for context-induced fear, not simply fear expression. Thus, the
conclusion can be made that the dHipp β-AR activation mediates contextual fear memory
retrieval.
The dHipp is also important for expression of contextual drug-associated
memories. Immediate early genes are expressed within the dHipp following exposure to
a previously drug-paired environment (Zhou and Zhu, 2006; Hearing et al., 2010).
Moreover, lesions or pharmacological inactivation of dHipp prevents drug-induced CPP
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expression (Meyers et al., 2003; Meyers et al., 2006; Zarrindast et al., 2006). Thus,
dHipp activity is critical for expression of drug-associated CPP memories.
Evidence reveals that dHipp activity is critical for retrieval of drug-associated
self-administration memories. Specifically, dHipp inactivation prevents context-induced
reinstatement of cocaine self-administration (Fuchs et al., 2005). In contrast, dHipp
inactivation has no effect on discrete cue-induced reinstatement or cocaine-induced
reinstatement of cocaine self-administration. These data reveal that dHipp activation is
necessary for context-induced cocaine seeking, and not simply expression of cocaine
seeking. Thus, the conclusion can be made that dHipp activation is required for retrieval
of contextual drug-associated memories within the self-administration paradigm.

Retrieval versus reconsolidation impairments: distinct or identical mechanisms?
The results described above reveal that PL-mPFC, BLA, and dHipp are involved
in the expression of fear and drug-associated memories. As described above, we found
that disruption of central β-AR activation induces persistent impairments in retrieval of a
cocaine-induced CPP memory (Otis and Mueller, 2011). Thus, given the role of these
structures in memory retrieval, we hypothesized that β-AR activity within PL-mPFC,
BLA, or dHipp may be critical for maintaining cocaine-induced CPP memory retrieval.
When considering the involvement of a structure in the maintenance of memory
retrieval, it is critical to also consider memory reconsolidation. Specifically, any
manipulations that induce persistent CPP disruption can be explained by 1) a persistent
memory retrieval disruption, 2) a transient impairment in behavioral expression of the
CPP along with blockade of memory reconsolidation, or 3) persistent impairment in CPP
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expression due to effects that are unrelated to memory retrieval or reconsolidation (e.g.,
long-lasting motor impairments). Moreover, whether the maintenance of retrieval
requires distinct or identical mechanisms as stabilization of memory for reconsolidation
had not been examined. Thus, I next discuss the possible involvement of PL-mPFC,
BLA, and dHipp in memory reconsolidation.

Neurobiological mechanisms of memory reconsolidation
PL-mPFC involvement in memory reconsolidation
Above I describe data supporting PL-mPFC involvement in expression of fear
and drug-associated memories. However, very few investigations have examined the role
of PL-mPFC in memory reconsolidation. PL-mPFC protein synthesis inhibition has been
shown to impair the consolidation, but not reconsolidation, of a trace fear memory (Blum
et al., 2006). In contrast, PL-mPFC inactivation or α1-AR blockade impairs fear memory
reconsolidation (Do Monte et al., 2013; Stern et al., 2013). For drug-associated
memories, one study revealed that PL-mPFC inactivation or protein synthesis inhibition
following context re-exposure had no effect on subsequent context-induced cocaine selfadministration (Ramirez et al., 2009). Taken together, although some studies support PLmPFC involvement in memory reconsolidation, this area of research has been mostly
ignored.

BLA involvement in memory reconsolidation
In contrast to PL-mPFC, many studies have revealed a critical role of the BLA for
the stabilization of memory during reconsolidation. This was first demonstrated with fear
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conditioning, as BLA microinfusions of the protein synthesis inhibitor anisomycin
immediately following CS exposure impairs fear expression during a subsequent CS test
(Nader et al., 2000). Moreover, BLA anisomycin infusions also prevented reinstatement
and spontaneous recovery of the fear memory (Duvarci and Nader, 2004), suggesting
possible memory ablation. Similarly, BLA β-AR blockade prevents the reconsolidation,
but not consolidation, of an auditory fear memory (Debiec and Ledoux, 2004). Thus,
BLA β-AR signaling, including downstream PKA activation, may be critical for
reconsolidation. Indeed, BLA PKA inhibition prevents fear memory reconsolidation,
whereas BLA PKA activation enhances fear memory reconsolidation (Tronson et al.,
2006). Amygdalar β-AR signaling may also be critical for reconsolidation of human
memories. Oral administration of the β-AR antagonist propranolol prevents
reconsolidation of fear memories in humans (Kindt et al., 2009; Schwabe et al., 2013).
Furthermore, experiments using fMRI reveal that disruption of reconsolidation in humans
prevents the BLA from responding to presentation of the CS (Agren et al., 2012). Taken
together, BLA β-AR signaling is critical for the reconsolidation of fear memories.
Evidence also reveals BLA involvement in reconsolidation of drug-associated
memories. Initial experiments demonstrated that ablation of BLA zif268 (an immediate
early gene involved in synaptic plasticity) during cue presentation impairs subsequent
cue-induced cocaine self-administration (Lee et al., 2005; Lee et al., 2006). Moreover,
disruption of amygdalar NMDAr (N-methyl D-aspartate receptor) activation also disrupts
reconsolidation of cue-induced cocaine self-administration (Milton et al., 2008).
Pharmacological or genetic disruption of BLA activity also impairs drug-associated CPP
memory reconsolidation (Li et al., 2010; Theberge et al., 2010; Wu et al., 2011). This
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includes β-AR signaling, as inactivation of BLA β-ARs or downstream PKA prevents
cocaine-induced CPP memory reconsolidation (Bernardi et al., 2009; Arguello et al.,
2013). Taken together, BLA activity, including β-AR signaling, is critical for
reconsolidation of drug-associated memories.

dHipp involvement in memory reconsolidation
The dHipp is critical for reconsolidation of contextual memories. In a contextual
fear conditioning paradigm, dHipp protein synthesis inhibition following presentation of
a fear-associated context disrupts subsequent context-induced fear (Debiec and Ledoux,
2004; Lee et al., 2004). In the self-administration paradigm, dHipp inactivation but not
protein synthesis inhibition following context exposure disrupts subsequent contextinduced reinstatement (Ramirez et al., 2009). Moreover, unilateral dHipp inactivation
along with contralateral BLA protein synthesis inhibition following context exposure
disrupts subsequent context-induced drug self-administration (Wells et al., 2011). In
contrast, either manipulation alone has no effect. These data indicate that dHipp activity
following presentation of contextual cues may be required for protein synthesisdependent reconsolidation processes in the BLA. In the CPP paradigm, research reveals
that disruption of dHipp protein synthesis or PKA following exposure to a morphinepaired context disrupts subsequent morphine-induced CPP expression (Milekic et al.,
2006; Taubenfeld et al., 2010). As PKA and protein synthesis are downstream of β-AR
signaling, these data indicate that reconsolidation of drug-associated CPP memories may
require dHipp β-AR signaling.
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Localizing the effects of β-AR blockade on cocaine CPP memory retrieval
The data above describe a critical role for PL-mPFC, BLA, and dHipp in retrieval
and/or reconsolidation of fear and drug-associated memories. We previously revealed
that β-AR blockade induces persistent cocaine CPP memory retrieval impairments. Thus,
we next targeted PL-mPFC, BLA, and dHipp with β-AR antagonists before and after a
CPP retrieval test to determine the effects of these manipulations on drug-associated
memory retrieval and reconsolidation.
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Otis, Dashew, and Mueller, 2013
We first determined the necessity of β-AR activation within the PL-mPFC for
retrieval of a cocaine-induced CPP by administering β-AR antagonists before a CPP
retrieval test. Following conditioning, rats were given PL-mPFC microinfusions of saline
or propranolol before the second CPP test. Microinfusions of propranolol, but not saline,
prevented CPP expression during the second test and during a subsequent microinfusionfree test (see Figure 7B). We next replicated these findings, but rats were given PLmPFC microinfusions of saline or the more selective β-AR antagonist nadolol before the
first CPP test. Rats treated with saline expressed a CPP for the previously cocaineassociated chamber during all CPP tests, whereas rats treated with nadolol did not (see
Figure 7C). Moreover, PL-mPFC microinfusions of propranolol or nadolol did not affect
locomotor activity, as measured by photobeam breaks during a CPP test (see Figure 7D
and Figure 7E). Thus, PL-mPFC microinfusions of β-AR antagonists induced a
persistent impairment in expression of a cocaine-induced CPP without affecting
locomotor activity.
We next determined the necessity of β-AR activation within the BLA for retrieval
of a cocaine-induced CPP. Following conditioning, rats were given BLA microinfusions
of saline or propranolol before the second CPP test. Microinfusions of propranolol had
no effect on CPP during the second CPP test. However, propranolol-treated rats
expressed no CPP during the subsequent microinfusion-free test (see Figure 8B). We
next replicated these findings, but rats were given BLA microinfusions of saline or
nadolol before the first CPP test. Rats treated with saline expressed a CPP for the
previously cocaine-associated chamber during all CPP tests, whereas rats treated with

32

nadolol only expressed a CPP during the first CPP test (see Figure 8C). BLA
microinfusions of propranolol or nadolol did not affect locomotor activity, as measured
by photobeam breaks during a CPP test (see Figure 8D and Figure 8E). Thus, BLA
microinfusions of β-AR antagonists did not prevent initial expression of the CPP.
However, BLA β-AR blockade did prevent CPP expression during subsequent
microinfusion-free tests, indicating that BLA β-AR activation may be necessary for CPP
memory reconsolidation.
We next determined if CPP expression deficits induced by PL-mPFC and BLA βAR blockade were due to disruption of memory reconsolidation. First, following
conditioning, rats were given PL-mPFC microinfusions of saline or nadolol immediately
after the first CPP test. Rats treated with either saline or nadolol expressed a CPP across
all tests, indicating that PL-mPFC nadolol microinfusions had no effect on CPP
expression (see Figure 9A). Second, following conditioning rats were given BLA
microinfusions of saline or nadolol immediately after the first CPP test. Rats treated with
saline expressed a CPP for the previously cocaine-associated chamber during all CPP
tests, whereas rats treated with nadolol only expressed a CPP during the first CPP test
(see Figure 9B). Thus, β-AR blockade in BLA, but not PL-mPFC, prevented the
reconsolidation of a cocaine CPP memory. These results are consistent with data
revealing that microinfusions of a β2-AR antagonist after a cocaine CPP test also
attenuate subsequent CPP expression (Bernardi et al., 2009).
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We next confirmed that the observed findings were not due to nonspecific effects
of PL-mPFC and BLA microinfusions on memory expression. We already demonstrated
that PL-mPFC or BLA propranolol and nadolol microinfusions do not affect locomotor
activity. Next, we evaluated the effects of PL-mPFC or BLA β-AR blockade in the
absence of a CPP test. Following conditioning, rats were given PL-mPFC or BLA
microinfusions of nadolol in the absence of testing, following by a single microinfusionfree CPP test the following day. Rats that received microinfusions of saline or nadolol
expressed an equivalent CPP during this test (see Figure 10), indicating that the effects of
PL-mPFC and BLA β-AR blockade on CPP expression require memory reactivation (i.e.,
the CPP test). Finally, we determined whether PL-mPFC or BLA β-AR blockade induces
an affective state capable of altering CPP expression. Rats received PL-mPFC or BLA
microinfusions of nadolol in one chamber, and saline in another. Following nadolol
conditioning, rats were exposed to all chambers for a nadolol-induced CPP test. Rats did
not express a CPP or aversion for the previously nadolol-paired chamber (see Figure 11),
indicating that nadolol did not induce an affective state capable of influencing CPP
expression.
Our findings demonstrate that PL-mPFC β-AR activation during, but not after, a
CPP test is critical for subsequent CPP expression. Moreover, these effects were not due
to reconsolidation blockade or nonspecific effects on behavioral expression of the CPP.
These data lead to the conclusion that PL-mPFC β-AR activation maintains cocaineassociated CPP memory retrieval. Thus, we provide the first evidence that the
maintenance of retrieval requires neural mechanisms that are completely distinct from
those required for stabilization of memory during reconsolidation. We have now further
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examined the dissociation between retrieval deficits and reconsolidation blockade by
evaluating the role of dHipp β-AR activation in retrieval and reconsolidation of a
cocaine-induced CPP memory (Otis et al., 2014a).
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Figures: Otis, Dashew, and Mueller, 2013
Figure 7

Figure 7. PL-mPFC β-AR blockade persistently impairs cocaine CPP memory retrieval.
(A) Coronal drawings (bregma, +3.72) showing injector tip placements of PL-mPFC
microinfusions. (B) PL-mPFC microinfusions of propranolol, but not saline, before the
second CPP trial persistently impair CPP expression. (C) PL-mPFC microinfusions of
nadolol, but not saline, before the first CPP trial induced a persistent deficit in CPP
expression. PL-mPFC microinfusions of (D) propranolol or (E) nadolol did not affect
locomotor activity, as measured by photobeam breaks during a CPP trial (Otis et al.,
2013). ***p < 0.001, **p < 0.01, and *p < 0.05.
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Figure 8

Figure 8. BLA β-AR blockade does not block initial CPP memory retrieval. (A)
Coronal drawings (bregma, -2.76) showing injector tip placements of BLA
microinfusions. BLA microinfusions of (B) propranolol before the second CPP trial or
(C) nadolol before the first CPP trial did not affect initial CPP expression, but prevented
CPP expression during subsequent trials. BLA microinfusions of (D) propranolol or (E)
nadolol did not affect locomotor activity, as measured by photobeam breaks during a CPP
trial (Otis et al., 2013). ***p < 0.001, **p < 0.01, and *p < 0.05.
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Figure 9

Figure 9. BLA but not PL-mPFC β-AR blockade impairs reconsolidation of a cocaine
CPP memory. (A) Coronal drawings (bregma, +3.72) showing injector tip placements of
PL-mPFC microinfusions. (B) PL-mPFC microinfusions of nadolol after a CPP trial did
not prevent CPP expression during subsequent trials. (C) Coronal drawings (bregma, 2.76) showing injector tip placements of BLA microinfusions. (D) BLA microinfusions
of nadolol, but not saline, after a CPP trial prevent CPP expression during subsequent
trials (Otis et al., 2013). ***p < 0.001, **p < 0.01, and *p < 0.05.
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Figure 10

Figure 10. PL-mPFC and BLA β-AR blockade in the absence of retrieval does not
prevent CPP expression. PL-mPFC (left) or BLA (right) microinfusions of nadolol do
not prevent CPP expression during a CPP trial 24 hours later (Otis et al., 2013). ***p <
0.001 and **p < 0.01.
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Figure 11

Figure 11. PL-mPFC and BLA β-AR blockade does not induce a CPP or aversion.
Following conditioning with PL-mPFC or BLA microinfusions nadolol or saline, rats
spent an equivalent amount of time within previously nadolol- and saline-paired
chambers (Otis et al., 2013).
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Otis, Fitzgerald, and Mueller, 2014a
We next determined the necessity of β-AR activation within the dHipp for
retrieval of a cocaine-induced CPP by administering nadolol before a CPP retrieval test.
Following conditioning, rats were given dHipp microinfusions of saline, a low dose of
nadolol (1µg/µl) or a higher dose of nadolol (2µg/µl) before the first CPP test. Rats
treated with saline or the low dose of nadolol expressed a CPP for the previously cocaineassociated chamber during all CPP tests, whereas rats treated with the high dose of
nadolol did not (see Figure 12B). To determine if this effect required the CPP test, or
simply required exposure to the previously cocaine-paired chamber, we replicated the
experiment but only exposed the rats to the previously cocaine-paired chamber following
dHipp microinfusions. Rats were then given daily CPP tests, during which previously
saline-treated rats expressed a CPP, whereas previously nadolol-treated rats did not (see
Figure 12C). Thus, dHipp microinfusions of nadolol induced a persistent impairment in
expression of a cocaine-induced CPP when administered before a CPP test or when
administered before exposure to the previously cocaine-paired chamber.
We next determined the effects of dHipp β-AR blockade on subsequent cocaineinduced reinstatement of the CPP. Rats that were previously treated with dHipp nadolol
or saline before the first CPP test (as described above; see Figure 12) were given a week
break from testing. Two final CPP tests were then given, during which no groups
expressed a CPP. The following day, rats previously treated with saline or the low dose
of nadolol expressed cocaine-induced (5 mg/kg) reinstatement of the CPP, whereas rats
previously treated with the high dose of nadolol did not (see Figure 13A). We next
replicated these findings, but administered a higher dose of cocaine during the cocaine-
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induced reinstatement test (10 mg/kg). Consistent with the previous finding, rats
previously treated with saline expressed cocaine-induced reinstatement of the CPP,
whereas rats previously treated with the high dose of nadolol did not (see Figure 13B).
Thus, dHipp nadolol-induced CPP expression deficits provided long-lasting protection
against cocaine-induced reinstatement of the CPP.
We also investigated whether dHipp β-AR blockade-induced CPP expression and
reinstatement deficits are due to disruption of memory reconsolidation. Following
conditioning, rats were given dHipp microinfusions of saline or nadolol immediately after
the first CPP test. Rats treated with saline expressed a CPP during the first, second, and
third test whereas rats treated with nadolol expressed a CPP during the first, third, and
fourth test (see Figure 14B). Thus, although nadolol may have impaired CPP expression
during the second CPP test, this effect was transient. These findings indicate that CPP
reconsolidation is not completely disrupted by dHipp β-AR blockade. We next
determined the effects of post-test dHipp β-AR blockade on subsequent cocaine-induced
reinstatement of the CPP. Following a week break from testing, rats were given a final
CPP trial, during which neither saline nor nadolol-treated rats expressed a CPP. The
following day, rats previously treated with saline or nadolol expressed cocaine-induced
reinstatement of the CPP (see Figure 14C). Thus, post-test nadolol microinfusions did
not induce long-lasting CPP expression deficits and did not provide protection against
cocaine-induced reinstatement of the CPP.
We next confirmed that the observed findings were not due to nonspecific effects
of dHipp microinfusions on memory expression. We first evaluated the effects of dHipp
β-AR blockade in the absence of a CPP test. Following conditioning, rats were given
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dHipp microinfusions of nadolol in the absence of testing, following by a single
microinfusion-free CPP test the following day. Rats that received microinfusions of
saline or nadolol expressed an equivalent CPP during this test (see Figure 15A). Next,
we determined whether dHipp β-AR blockade induces an affective state capable of
influencing CPP expression. Rats received dHipp microinfusions of nadolol in one
chamber, and saline in another. Following nadolol conditioning, rats were exposed to all
chambers for a nadolol-induced CPP test. Rats did not express a CPP or aversion for the
previously nadolol-paired chamber (see Figure 15B), indicating that nadolol did not
induce an affective state capable of influencing CPP expression. Finally, dHipp
microinfusions of nadolol did not affect locomotor activity, as measured by photobeam
breaks during a CPP test (see Figure 15C).
Our findings demonstrate that dHipp β-AR activation during, but not after, a CPP
test is critical for subsequent CPP expression. Moreover, these effects were not due to
reconsolidation blockade or nonspecific effects on behavioral expression of the CPP.
Thus, the conclusion can be made that dHipp β-AR activation is necessary for
maintaining cocaine-induced CPP memory retrieval.
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Figures: Otis, Fitzgerald, and Mueller, 2014
Figure 12

Figure 12. dHipp β-AR blockade persistently impairs cocaine CPP memory retrieval.
(A) Coronal drawings (bregma, -3.24 mm) showing injector tip placements of dHipp
microinfusions. (B) dHipp microinfusions of a high dose of nadolol, but not a low dose
or saline, before the first CPP trial persistently impair CPP expression. (C) dHipp
microinfusions of nadolol, but not saline, before exposure to the previously cocainepaired chamber only prevented CPP expression during subsequent CPP trials (Otis et al.,
2014a). ***p < 0.001, **p < 0.01, and *p < 0.05.
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Figure 13

Figure 13. Retrieval impairments induced by dHipp β-AR blockade prevent cocaineinduced reinstatement. Rats treated with saline or nadolol before an initial CPP trial
expressed no CPP during the final CPP extinction trials. Following injections of a (A)
low or (B) high dose of cocaine, rats previously treated with dHipp microinfusions of
saline or the low dose of nadolol, but not the high dose of nadolol, expressed cocaineinduced reinstatement of the CPP (Otis et al., 2014a). ***p < 0.001 and *p < 0.05.
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Figure 14

Figure 14. dHipp β-AR blockade does not abolish CPP memory reconsolidation. (A)
Coronal drawings (bregma, -3.24 mm) showing injector tip placements of dHipp
microinfusions. (B) dHipp microinfusions of a nadolol did not prevent rats from
expressing a CPP during subsequent trials. (C) Rats treated with saline or nadolol
expressed no CPP during the final CPP extinction trial. Rats previously treated with
dHipp microinfusions of saline or nadolol after the first CPP trial expressed cocaineinduced reinstatement of the CPP (Otis et al., 2014a). ***p < 0.001, **p < 0.01, and *p <
0.05.
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Figure 15

Figure 15. Effects of dHipp nadolol microinfusions on CPP expression are not due to
nonspecific effects. (A) dHipp microinfusions of nadolol did not prevent rats from
expressing a CPP 24 hours later. (B) Following conditioning with dHipp microinfusions
of nadolol or saline, rats spent an equivalent amount of time within previously nadololand saline-paired chambers. (C) dHipp microinfusions of nadolol not affect locomotor
activity, as measured by photobeam breaks during a CPP trial (Otis et al., 2014a). ***p <
0.001, **p < 0.01, and *p < 0.05.
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Proposed model of drug-associated memory retrieval
The experiments described throughout this dissertation reveal some basic neural
mechanisms required for memory retrieval. Next, I use these and other studies to
illustrate a likely system that is required for (and maintains) drug-associated memory
retrieval (see Figure 16).
PL-mPFC is necessary for retrieval of learned fear (Corcoran and Quirk, 2007)
and drug-associated memories (Otis et al., 2013). Relapse to drug seeking involves
perturbations in particular PL-mPFC outputs which synapse onto nucleus accumbens core
(NAcc) medium spiny neurons (Kalivas et al., 2005). NAcc glutamatergic receptor
activity is critical for reinstatement of drug seeking (Fuchs et al., 2004; LaLumiere and
Kalivas, 2008), and NAcc extracellular glutamate levels increase during reinstatement
(Baker et al., 2003; McFarland et al., 2003). Moreover, PL-mPFC microinfusions of
brain-derived neurotrophic factor (BDNF) or GABA receptor agonists prevent
reinstatement and prevent the rise in NAcc extracellular glutamate (McFarland et al.,
2003; Berglind et al., 2009). Thus, PL-mPFC likely provides glutamatergic input to the
NAcc, which drives behavioral expression of drug seeking.
The PL-mPFC has reciprocal projections with the BLA (Ishikawa and Nakamura,
2003; Gabbott et al., 2005), a structure that is also critical for drug-associated memory
retrieval (Grimm and See, 2000). Moreover, evidence reveals that the BLA may activate
PL-mPFC for retrieval.

First, disconnection of these structures via contralateral

inactivation prevents cue-induced reinstatement of cocaine seeking (Mashhoon et al.,
2010). Second, PL-mPFC projecting BLA neurons express immediate early genes
following exposure to a previously cocaine-associated environment (Miller and Marshall,

48

2005). In contrast, although some PL-mPFC neurons also express more immediate early
genes upon context exposure, those neurons do not project back to the BLA (Miller and
Marshall, 2005). Taken together, BLA neurons drive PL-mPFC activation for drugassociated memory retrieval.
The dHipp provides input to the BLA and has indirect projections to the PLmPFC through its ventral subregion and through the nucleus reuniens of the thalamus
(Hoover and Vertes, 2007; Vertes et al., 2007). Considering the role of the dHipp in
contextual fear and drug-associated memory retrieval (Corcoran and Maren, 2001; Fuchs
et al., 2005), dHipp likely provides contextual information to BLA and PL-mPFC for
memory retrieval.
Finally, nuclei of noradrenergic neurons, such as the locus coeruleus (LC) and
nucleus tractus solitarius (NTS) reside within the brainstem. Our data suggest that
noradrenergic neurons secrete norepinephrine within PL-mPFC and dHipp to support
drug-associated memory retrieval. In support of this, presentation of salient cues leads to
norepinephrine release (Cassens et al., 1980). Moreover, artificial enhancement of NE
release via direct stimulation of LC neurons enhances behavioral expression of memory
(Sara and Devauges, 1988), an effect that is dependent on β-AR activation (Devauges and
Sara, 1991). NE release is known to activate PL-mPFC and dHipp β-ARs (Pedarzani and
Storm, 1993; Otis et al., 2013), and we found that this activation is critical for cocaineinduced CPP memory retrieval (Otis et al., 2013; Otis et al., 2014a). Thus, brainstem
noradrenergic neurons become active following presentation of salient cues, and this
activity allows memory retrieval. Interestingly, although most memory studies have
focused on LC neurons, some data hint that NTS neurons may be critical for drug-
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associated memory retrieval. Specifically, data reveal that genetic deletion of
norepinephrine, via knockout of norepinephrine-synthesizing enzyme dopamine βhydroxylase, prevents drug-induced CPP expression (Jasmin et al., 2006; Olson et al.,
2006). Moreover, restoration of norepinephrine within the NTS rescues these
impairments (Olson et al., 2006). Thus, norepinephrine released from the NTS may be
critical for drug-associated memory retrieval. However, further investigations must be
completed to confirm this hypothesis.
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Figure 16

Figure 16. Proposed model of drug-associated memory retrieval. Brainstem nuclei
(LC/NTS) release norepinephrine into forebrain structures (dHipp, PL-mPFC). These
structures, including the BLA, interact to promote cocaine-associated memory expression
through NAcc-projecting PL-mPFC neurons. LC, locus coeruleus; NTS, nucleus tractus
solitarius; vHipp, ventral hippocampus; dHipp, dorsal hippocampus; PL, prelimbic
medial prefrontal cortex; NAcc, nucleus accumbens core.
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Prelimbic β-AR activation enhances synaptic plasticity and intrinsic excitability
The data described demonstrate that PL-mPFC input, including noradrenergic
input for β-AR activation, is required for memory retrieval. However, the mechanism by
which β-AR activation maintains retrieval is unknown. Next, I describe research
regarding the effects of β-AR activation on synaptic and intrinsic neuronal activity.
Moreover, I use this research to describe a possible mechanism by which β-AR activity
maintains retrieval.

β-AR activation enhances synaptic plasticity
Synaptic strength is modified by the strength and timing of presynaptic inputs
(Bliss and Lomo, 1973; Levy and Steward, 1979; Malenka and Nicoll, 1999). This
synaptic plasticity is a likely mechanism of learning, as learning is associated with
synaptic plasticity within brain regions that are required for that learning (McKernan and
Shinnick-Gallagher, 1997; Rogan et al., 1997; Whitlock et al., 2006). Moreover,
mechanisms that are required for synaptic plasticity, including glutamate receptor
activity, are also important for learning (Morris et al., 1986; Artola and Singer, 1987;
Kleinschmidt et al., 1987; Miserendino et al., 1990; Tsien et al., 1996; Malenka and
Nicoll, 1999; Tang et al., 1999). Thus, synaptic plasticity is a likely mechanism of
learning and memory.
Synaptic plasticity is regulated by β-AR activation, although the exact role of βAR activity in synaptic plasticity varies depending on the brain region (O'Dell et al.,
2010). Studies reveal that NE or β-AR agonists enhance electrically-evoked long-term
potentiation (LTP) at hippocampal mossy fiber synapses (Hopkins and Johnston, 1984).
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Moreover, NE and β-AR agonists enhance LTP at these synapses via both presynaptic
and postsynaptic mechanisms (Hopkins and Johnston, 1988; Huang and Kandel, 1996).
β-AR agonists also promote spike-timing dependent plasticity (STDP) at mPFC
pyramidal neuron synapses (Zaitsev and Anwyl, 2012), although the exact mechanism by
which β-AR activation facilitates mPFC plasticity is unclear. Recently, studies revealed
that mPFC β-AR activation increases evoked excitatory postsynaptic currents (eEPSCs)
by increasing presynaptic neurotransmitter release and by enhancing NMDAr channel
conductance (Huang and Hsu, 2006; Zaitsev and Anwyl, 2012). Taken together, NEinduced β-AR activation may facilitate mPFC synaptic plasticity by 1) increasing
presynaptic glutamate release and 2) by enhancing postsynaptic NMDAr channel
conductance.

β-AR activation enhances intrinsic excitability
Intrinsic excitability can be defined as the electrical properties of a neuronal
membrane that are independent of synaptic activity. For example, EPSP propagation and
properties of the action potential (e.g., threshold, amplitude, width, and adaptation) are
not dependent on synaptic input. Intrinsic excitability is modulated by experience
(Woody and Black-Cleworth, 1973; Alkon, 1974; Disterhoft et al., 1986; Moyer et al.,
1996) and by neuromodulators, including NE (Madison and Nicoll, 1982, 1986b, a;
Pedarzani and Storm, 1993). In hippocampal and infralimbic mPFC pyramidal neurons,
NE reduces the slow afterhyperpolarization (sAHP) and limits spike frequency
adaptation, effects that are blocked by β-AR antagonists (Madison and Nicoll, 1982,
1986a, b; Pedarzani and Storm, 1993; Mueller et al., 2008). Thus, β-AR activation
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enhances the intrinsic excitability of hippocampal and infralimbic mPFC pyramidal
neurons. However, the effect of β-AR activation on the excitability of PL-mPFC
pyramidal and GABAergic neurons was unknown.
Using patch-clamp electrophysiology, we determined the effects of β-AR
activation on PL-mPFC pyramidal cell and GABAergic interneuron excitability.
Pyramidal neurons were identified based on the presence of an apical dendrite, and this
morphology was subsequently confirmed via immunohistochemistry (see Figure 17A).
Following baseline recordings, action potentials were evoked by brief current pulses (see
Figure 17B). Application of NE increased the number of evoked action potentials (see
Figure 17C). Moreover, NE, caused membrane depolarization, decreased rheobase, and
reduced action potential latency (see Table 2), all of which indicate enhanced intrinsic
excitability. These changes were not present in neurons that were treated with both
propranolol and NE, indicating that NE increases the intrinsic excitability of PL-mPFC
pyramidal neurons via β-AR activation. Finally, although NE had no effect on the fast
AHP (fAHP) in pyramidal neurons, NE transformed the sAHP to a slow
afterdepolarization (see Figure 17D). As the sAHP limits AP frequency (Wu et al., 2004),
reversal of the sAHP is a likely mechanism by which β-AR activation enhances the
number of evoked action potentials. Consistent with this, propranolol prevented NE from
reversing the sAHP (see Figure 17E).
Although the primary output neurons of the PL-mPFC are pyramidal neurons,
these neurons function within a network of GABAergic interneurons. Thus, we next
evaluated the effects of β-AR activation on the intrinsic excitability of GABAergic
interneurons. GABAergic interneurons were identified by morphology (lack of apical
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dendrite), electrophysiological characteristics (see Table 1), and by streptavidin and
GAD67 co-immunoreactivity (see Figure 18A). Similar to pyramidal neurons,
application of NE increased the number of evoked action potentials (see Figure 18C).
Moreover, NE caused membrane depolarization, decreased rheobase, and reduced action
potential latency (see Table 3), all of which indicate enhanced intrinsic excitability. These
changes were not present in GABAergic interneurons that were treated with both
propranolol and NE, indicating that NE increases the intrinsic excitability of these
neurons via β-AR activation. Unlike pyramidal neurons, NE had no effect on the sAHP
of GABAergic interneurons (see Table 3). This finding is consistent with data revealing
that these neurons lack a sAHP (McCormick et al., 1985). In contrast, NE reduced the
fAHP, (see Figure 17D), and this effect was blocked by co-application of propranolol
(see Figure 17E). Thus, β-AR activation may enhance the intrinsic excitability of
GABAergic interneurons by reducing the fAHP.
The data described reveal that β-AR activation strengthens synaptic activity
within the mPFC (e.g., STDP and NMDAr currents) and enhances intrinsic excitability of
PL-mPFC pyramidal and GABAergic interneurons. Below I describe a possible
mechanism by which these changes may maintain memory retrieval.
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Table 1
Neuron

RN (MΩ)

Vm (mV)

APwidth (ms)

APamp (mV)

fAHP (mV)

sAHP (mV)

Pyramidal

125 ± 11

-69 ± 2

2.6 ± 0.2

67 ± 2

-6.4 ± 0.6

-0.7 ± 0.1

GABA

310 ± 6***

-66 ± 1

2.1 ± 0.1**

61 ± 2*

-13.6 ±0.8***

-0.0 ± 0.1***

Table 1. Basic membrane properties of PL-mPFC pyramidal and GABA neurons.
PL-mPFC GABAergic neurons had larger input resistance and fAHP, but smaller AP
width and sAHP as compared with pyramidal neurons. APwidth, action potential width;
APamp, action potential amplitude; RN, input resistance; Vm, Resting membrane potential;
fAHP, fast afterhyperpolarization; sAHP, slow afterhyperpolarization. ***p < 0.001 and
*p < 0.05 as compared with pyramidal neurons (Otis et al., 2013).
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Figure 17

Figure 17. β-AR blockade prevents NE from enhancing intrinsic excitability of PLmPFC pyramidal neurons. (A) Example photomicrograph of biocytin-filled PL-mPFC
pyramidal neuron. (B) Example traces revealing that NE increased the number of
evoked action potentials. (C) Grouped data reveal that NE-induced enhancement of
evoked action potentials was blocked by propranolol. (D) Example traces revealing that
NE decreased the sAHP. (E) Grouped data reveal that NE-induced reduction of sAHP
was blocked by propranolol (Otis et al., 2013). Prop, propranolol; *p < 0.05.
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Figure 18

Figure 18. β-AR blockade prevents norepinephrine from enhancing intrinsic excitability
of PL-mPFC GABAergic interneurons. (A) Example photomicrograph of biocytin-filled
PL-mPFC GABAergic interneuron. (B) Example traces revealing that NE increased the
number of evoked action potentials. (C) Grouped data reveal that NE-induced
enhancement of evoked action potentials was attenuated by propranolol. (D) Example
traces revealing that NE decreased the fAHP. (E) Grouped data reveal that NE-induced
reduction of fAHP was blocked by propranolol (Otis et al., 2013). Prop, propranolol; **p
< 0.01.
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Table 2
Drug
NE
Prop
+ NE

Time

RN (MΩ)

Vm (mV)

Rheo (pA)

APthresh (mV)

AP latency (ms)

fAHP (mV) sAHP (mV)

Pre

121± 24

-70 ± 3

223 ± 75

-40 ± 2

118 ± 18

-7.3 ± 0.7

-0.5 ± 0.2

Post

124 ± 30

-65 ± 3**

173 ± 74** -39 ± 1

53 ± 8**

-7.7 ± 1.1

0.3 ± 0.2*

Pre

132 ± 13

-69 ± 4

93 ± 11

-41 ± 5

130 ± 28

-5.6 ± 1.3

-0.9 ± 0.3

Post

149 ± 12

-68 ± 4

88 ± 18

-41 ± 4

102 ± 29

-4.5 ± 1.6

-0.9 ± 0.3

Table 2. Effects of NE and propranolol on intrinsic excitability of PL-mPFC
pyramidal neurons. NE, norepinephrine; Prop, propranolol; RN, input resistance; Vm,
resting membrane potential; Rheo, rheobase; APthresh, action potential threshold; APlatency,
action potential latency; fAHP, fast afterhyperpolarization; sAHP, slow
afterhyperpolarization. *p < 0.05, **p < 0.01 as compared with before NE application
(Otis et al., 2013).
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Table 3
Drug
NE
Prop
+ NE

Time

RN (MΩ)

Vm (mV)

Rheo (pA)

APthresh (mV)

AP latency (ms)

fAHP (mV) sAHP (mV)

Pre

285 ± 56

-65 ± 2

74 ± 15

-42 ± 2

127 ± 35

-11 ± 0.9

0.0 ± 0.1

Post

231 ± 39

-60 ± 2**

31 ± 9**

-44 ± 2

32 ± 10**

-6.1 ±1.6**

0.0 ± 0.2

Pre

333 ± 52

-69 ± 3

58 ± 9

-44 ± 2

148 ± 44

-14.1 ± 1.0

-0.2 ± 0.2

Post

365 ± 53

-69 ± 3

39 ± 9*

-46 ± 2

83 ± 23

-13.1 ± 1.7

0.3 ± 0.4

Table 3. Effects of NE and propranolol on intrinsic excitability of PL-mPFC
GABAergic interneurons. NE, norepinephrine; Prop, propranolol; RN, input resistance;
Vm, resting membrane potential; Rheo, rheobase; APthresh, action potential threshold;
APlatency, action potential latency; fAHP, fast afterhyperpolarization; sAHP, slow
afterhyperpolarization. *p < 0.05, **p < 0.01 as compared with before NE application
(Otis et al., 2013).

60

Proposed mechanism of memory retrieval deficits: PL-mPFC synaptic depression
Salient cue exposure induces NE release, leading to β-AR activation (Cassens et
al., 1980). Thus, cocaine- or fear-associated cue exposure is likely to induce β-AR
activation, which is known to increase synaptic currents and intrinsic excitability of PLmPFC neurons (Ji et al., 2008; Otis et al., 2013). In support of this, exposure to a fearassociated CS increases the firing rate of PL-mPFC neurons (Burgos-Robles et al., 2009;
Sotres-Bayon et al., 2012), whereas spontaneous PL-mPFC activity is reduced by
systemic injections of propranolol (Rodriguez-Romaguera et al., 2009). In addition to
noradrenergic potentiation of PL-mPFC neurons, PL-mPFC activity during cue
presentation is dependent on glutamatergic input from the hippocampus and amygdala
(Sotres-Bayon et al., 2012). Taken together, PL-mPFC neurons are more responsive to
glutamate input during retrieval (due to NE-induced enhancement of EPSCs and intrinsic
excitability), increasing the likelihood that EPSCs will induce action potentials. On the
other hand, presynaptic input in the absence of synchronous postsynaptic action
potentials can induce synaptic depression (Froemke and Dan, 2002; Froemke et al.,
2005). Thus, PL-mPFC β-AR activation may maintain synchronous presynaptic and
postsynaptic activity during retrieval, whereas disruption of this synchrony likely
weakens PL-mPFC synapses. Consistent with this hypothesis, NE prevents spike-timing
dependent depression (STDD) at cortical synapses (Salgado et al., 2012). Thus, β-AR
blockade during retrieval may induce PL-mPFC synaptic depression, resulting in longterm retrieval impairments.

61

Dissertation Goal and Aims
Abnormally strong memories underlie drug addiction and fear disorders such as
PTSD. Preventing retrieval of these memories would alleviate these disorders. Above, I
describe three publications revealing that cocaine-associated CPP memory retrieval is
susceptible to persistent disruption (Otis and Mueller, 2011; Otis et al., 2013; Otis et al.,
2014a). Moreover, recent studies using humans reveal that β-AR blockade can induce
persistent disruption of visual and emotional memory retrieval (Kroes et al, 2010; Kroes
et al., 2012 SfN Abstracts). Although the human studies do not completely rule out
memory reconsolidation effects, such experiments indicate that β-AR blockade-induced
memory retrieval impairments may not be limited to cocaine CPP memories. Thus, the
goal of this dissertation is to characterize the mechanism of memory retrieval deficits and
determine whether retrieval of other memories is maintained by β-AR activity. This will
be accomplished in the two following aims.

Aim 1: Determine whether β-AR activation is a fundamental mechanism for
maintenance of memory retrieval. Here I focus on the necessity of PL-mPFC β-AR
activity for maintaining retrieval of fear memories. Specifically, I determine the effects
of PL-mPFC β-AR blockade on retrieval of 1) a contextual fear memory, 2) a delay fear
memory, and 3) a trace fear memory.

Aim 2: Evaluate the underlying mechanisms of memory retrieval impairments.
Next, I determined the underlying mechanism by which memory retrieval impairments
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occur. Using patch-clamp electrophysiology, I characterized the intrinsic and synaptic
properties of PL-mPFC neurons from adult rats that have retrieval impairments as
compared with rats from appropriate control groups.
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Methods
Subjects
Adult male Long-Evans rats weighing 300-325 grams were housed individually in
clear plastic cages with access to standard laboratory rat chow (Harlan Laboratories) and
water ad libitum unless otherwise noted. Rats were maintained on a 14 hour light/10
hour dark cycle (lights on at 7am) and were weighed and handled daily. All experimental
protocols were approved by the Institutional Animal Care and Use Committee at the
University of Wisconsin-Milwaukee in accordance with National Institutes of Health
guidelines.

Cannula surgery
PL-mPFC cannula surgeries were performed to allow PL-mPFC β-AR blockade.
Rats were anesthetized with ketamine/xylazine (90 mg/kg, 10.5 mg/kg, i.p.). Following
anesthetization, double-barrel guide cannula (26 gauge; Plastics One, Roanoke, VA) were
implanted within PL-mPFC (AP, +2.8; ML, ±0.6; DV, -2.9 mm relative to bregma).
Cannula were fixed into place with 3 stainless steel skull screws and grip cement.
Following surgery, rats were treated with an antibiotic (penicillin g procaine, 75,000 units
in 0.25 ml, s.c.) and an analgesic (carprofen, 5.0 mg in 0.1 ml, s.c.). Rats were given a
minimum of 7 days for recovery following surgeries, during which behavioral
experiments were not conducted. Stylets remained within the guide cannula following
surgery to maintain patency until microinfusions were performed.
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Drugs and microinfusions
Cocaine HCl (National Institute of Drug Abuse) was dissolved in sterile 0.9%
saline and was systemically administered (10 mg / kg). PL-mPFC β-AR blockade was
induced via infusions of nadolol (1.2 µg / 0.6 µl saline; Sigma-Aldrich) at 0.3 µl / side
over a 2 minute time period. Microinfusion injectors were left in place for a minimum of
1 minute following microinfusions.

Fear conditioning chamber
Fear conditioning was conducted within sound-attenuating chambers (MED
Associates, St. Albans,VT) containing an electrifiable floor of rods (23 4.8-mm stainless
steel bars spaced 1.3 cm apart), clear Plexiglas (front/back) and aluminum (side) walls, a
tone generator, and a house light. The conditioning chamber was cleaned with 10%
ethanol before conditioning. An alternative context was used for delay and trace fear
testing, and this context was equipped with infrared lighting, smooth, black fiberglass
floors, and striped black and white Plexiglas walls (front/back). The alternative context
was cleaned with ammonium hydroxide before each test.

Place conditioning apparatus
Place conditioning and testing were conducted in a 3-chamber apparatus
containing 2 distinguishable conditioning chambers (13” x 9” x 11.5”) separated by a
smaller center chamber (6” x 7” x 11.5”). One of the conditioning chambers contains
wire mesh flooring with white walls, whereas the other conditioning chamber has goldgrated flooring with a black wall. The smaller center chamber has aluminum sheeting as
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flooring and white walls. Each of the larger chambers contains two infrared photobeams
separated by 3”. If the beam furthest from the center chamber was broken, then the rat
was determined to be in the larger chamber. If only the beam closest to the center
chamber was broken, then the rat was determined to be in the center chamber.

Methods: Aim 1
Aim 1 was completed to determine whether β-AR activation is a fundamental
mechanism of memory retrieval.

Aim 1a: Contextual fear conditioning
Rats underwent foreground contextual fear conditioning, during which the
conditioning context was paired with an aversive foot shock. Rats were exposed to the
conditioning context for a 6 minute baseline period, followed by 4 presentations of a 1
second shock (0.8 mA). The shocks were separated by a 240 ± 20 second inter trial
interval followed by a 4 minute post-conditioning period.
Rats were next given daily context fear retrieval tests. To determine the necessity
of PL-mPFC β-AR activation for memory retrieval, 1 or 30 days after conditioning PLmPFC microinfusions of saline or nadolol were administered. Fifteen minutes later rats
were given a 3 minute context fear memory retrieval test within the original conditioning
chamber (Corcoran and Quirk, 2007). Following the microinfusion test, daily infusionfree tests continued to determine the long-lasting effects of β-AR blockade on context
fear memory retrieval. Following multiple unreinforced retrieval tests, rats undergo
extinction (Quirk and Mueller, 2008), allowing us to assess reinstatement of the fear
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memory. To induce reinstatement, rats were given a normal context retrieval test, but at
the end of the test a 1 second shock (0.8 mA) was presented. The rats were then tested
for reinstatement of fear the following day by giving an identical context test in the
absence of shock.

Aim 1b: Delay fear conditioning
Rats were trained to associate a white noise CS with a 1 second shock UCS.
Specifically, rats were exposed to the training context for a 6 minute baseline period,
followed by 4 pairings of the CS and UCS. The white noise (72 dB) CS was played for
10 seconds and co-terminated with the 1 second shock UCS (1 mA). The CS-UCS
pairings were presented with a 240 ± 20 second inter trial interval followed by a 4 minute
post-conditioning period.
Rats were next given daily delay fear retrieval tests. To determine the necessity
of PL-mPFC β-AR activation for memory retrieval, 1 or 30 days after conditioning PLmPFC microinfusions of saline or nadolol were administered. Fifteen minutes later rats
were exposed to the alternative context. Following a 2 minute baseline period, the CS
was presented for 2 minutes, followed by a 2 minute post CS period. Freezing during and
after the CS was quantified separately. Following the microinfusion test, daily infusionfree tests continued to determine the long-lasting effects of β-AR blockade on delay fear
memory retrieval. Finally, following extinction of delay fear rats were represented with
the shock UCS (1s; 1mA) immediately following a normal delay fear test. The rats were
then tested for reinstatement of fear the following day by giving an identical retrieval test
in the absence of shock.
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Aim 1c: Trace fear conditioning
Rats learned to predict the presentation of an aversive footshock UCS following
presentation of a tone CS. Rats were exposed to the training context for a 6 minute
baseline period, followed by 6 pairings of the CS and UCS. Specifically, a white noise
(72 dB) CS was presented for 10 seconds, followed by a 20 second interval, and finally a
1 second shock UCS (1 mA). The CS-UCS pairings were presented with a 240 ± 20
second inter trial interval followed by a 4 minute post-conditioning period.
Rats were next given daily trace fear retrieval tests. To determine the necessity of
PL-mPFC β-AR activation for memory retrieval, 1 or 30 days after conditioning PLmPFC microinfusions of saline or nadolol were administered. Fifteen minutes later rats
were exposed to the alternative context. Following a 2 minute baseline period, the CS
was presented for 2 minutes, followed by a 2 minute post CS period. Freezing during the
and after the CS was quantified separately. Following the microinfusion test, daily
infusion-free tests continued to determine the long-lasting effects of β-AR blockade on
delay fear memory retrieval. Finally, following extinction of trace fear rats were
represented with the shock UCS (1s; 1mA) immediately following a normal trace fear
test. The rats were then tested for reinstatement of fear the following day by giving an
identical retrieval test in the absence of shock.
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Figure 19

Figure 19. Summary of behavioral experiments as described in aim 1. Arrows represent
microinfusions 15 minutes before behavioral testing.
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Methods: Aim 2
Aim 2 was completed to determine the mechanism of memory retrieval
impairments.

Place conditioning
Baseline preferences were assessed by placing the rats into the center of the CPP
apparatus with full access to all 3 chambers 15 minutes. We previously demonstrated
that rats spend equivalent time within the larger conditioning chambers before
conditioning (Otis and Mueller, 2011). Thus, following baseline testing rats were
conditioned to associate one chamber, but not another, with cocaine in a pseudorandom
and counterbalanced fashion over 8 days. Injections of saline or cocaine were
administered immediately before each 20 minute conditioning session, during which rats
were confined to the appropriate chamber.

Experimental manipulations
Following conditioning, rats were given systemic injections of saline (CPP-S) or
propranolol (CPP-P) as previously described (Otis and Mueller, 2011). Twenty minutes
later each rat was given a CPP memory retrieval test, during which full access to all 3
chambers was allowed for 15 minutes. A final control group of rats received post-test
propranolol injections (CPP-PP), allowing us to determine assess the effects of
propranolol on CPP memory reconsolidation. The next day, rats were given a second
CPP retrieval test in the absence of saline or propranolol injections. To determine the
mechanism of propranolol-induced memory retrieval impairments, rats were sacrificed
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for electrophysiological recordings 1 hour following the second memory retrieval test
(Pattwell et al., 2012).

Patch-clamp electrophysiology
Patch-clamp recordings were established as previously described (Otis et al.,
2013; Otis et al., 2014b). Rats aged 3-6 months were anesthetized with pentobarbital,
and brains were quickly removed and transferred into ice-cold (0-2˚C) oxygenated (95%
O2 / 5% CO2) artificial cerebral spinal fluid (aCSF) composed of the following (in mM):
124 NaCl, 2.8 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 26 NaHCO3, and 20 dextrose.
Coronal slices 300 µm thick containing prefrontal cortex were taken using a vibratome
(Leica VT1200). Slices recovered in warm aCSF (32˚C) for approximately 30 minutes,
followed by incubation in room temperature aCSF for 0.5-8 hours. Next, slices were
transferred into a recording chamber and continuously perfused with aCSF (2 ml / min).
PL-mPFC layer V neurons were visualized with differential interference contrast using a
60X water-immersion lens mounted on an upright Eclipse FN1 microscope (Nikon
Instruments). Pyramidal neurons were identified based on the presence of an apical
dendrite, and GABAergic interneurons were identified based on the lack of an apical
dendrite (Otis et al., 2013). Whole cell recordings of pyramidal neurons were then
obtained using borosilicate glass pipettes with low resistance tips (2-4 ΜΩ) containing a
potassium gluconate-based internal solution composed of the following (in mM): 110 Kgluconate, 20KCl, 10 HEPES, 2 MgCl2, 2 ATP, 0.3 GTP, 10 phosphocreatine, 0.2%
biocytin, 7.3 pH, 280 mOsm. Synaptic recordings were obtained with voltage clamp,
whereas intrinsic excitability recordings were obtained with current clamp using the
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MultiClamp 700B amplifier connected to a Digidata 1440A digitizer (Molecular
Devices). The liquid-liquid junction potential (measured as 13 mV) was compensated for
throughout all recordings. All electrophysiological data were analyzed using Clampfit
(Molecular Devices).
The intrinsic excitability of PL-mPFC pyramidal neurons was investigated by
recording under current clamp. Neurons were held at -70 mV via direct somatic
stimulation to control for differences in resting membrane potential. Next, a series of 1
second depolarizing steps were applied (0 to 500 pA; 50 pA steps), and the number of
evoked action potentials was recorded. To quantify neuronal excitability, the rising slope
of action potentials (excitability slope) was quantified. Specifically, excitability slope
was measured as the number of action potentials by input (from 0 pA to the level of
somatic stimulation that induced the maximum number of action potentials).
Furthermore, the maximum number of action potentials evoked by a single depolarizing
step was measured for each neuron. These alternative intrinsic excitability indices
correct for differences in input resistance, as high input resistance can result in a large
decrease in action potentials when high intensities of somatic stimulation is applied.
Finally, the excitability protocols were also conducted in neurons held at resting
membrane potential to determine if differences in resting membrane potential may induce
modifications in intrinsic neuronal excitability.
Monosynaptic glutamatergic currents were recorded from PL-mPFC pyramidal
neurons in voltage-clamp mode. First, spontaneous EPSCs (sEPSCs) were recorded to
allow identification of both presynaptic (sEPSC frequency) and postsynaptic (sEPSC
amplitude) modifications in PL-mPFC. To record sEPSCs, neurons were held at -80 mV
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in the presence of the GABAA receptor antagonist picrotoxin for a minimum of 60
seconds. Next, EPSCs were evoked using presynaptic stimulation applied with a bipolar
concentric microelectrode placed within 250 µm of the recording electrode. Considering
that AMPAr EPSCs but not NMDAr EPSCs are detectable at -80 mV, we first measured
the maximum monosynaptic AMPAr EPSCs for each neuron at -80 mV via stepwise
presynaptic input. After identifying the maximum presynaptic input for monosynaptic
AMPAr EPSCs, we induced and averaged a minimum of 8 AMPA EPSCs (0.067 Hz)
using that intensity of presynaptic stimulation. Next, neurons were depolarized to -35
mV. Both AMPA and NMDA receptors contribute to the total excitatory current at -35
mV (Figure 21), and the relative amount of AMPAr current between -80 mV and -35 mV
is linear even if AMPArs are inward-rectifying (Clem and Huganir, 2010). Thus, a
minimum of 8 EPSCs were evoked (0.067 Hz) at -35 mV to assess the relative amount of
NMDAr current as compared with AMPAr current (AMPA:NMDA ratio). The
AMPA:NMDA ratio was then calculated by dividing the peak of averaged EPSCs at -80
mV by the peak at -35 mV. To confirm that this was an accurate calculation of the
AMPA:NMDA ratio, we recalculated the AMPA:NMDA ratio in a subset of neurons by
applying the NMDAr antagonist APV (50 µM) while recording evoked EPSCs at -35 mV
(0.067 Hz). The following equation was then used as the second index of the
AMPA:NMDA ratio:

EPSC after APV (AMPA)

EPSC before APV (AMPA+NMDA) – EPSC after APV (AMPA)
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Presynaptic plasticity was also characterized via the paired-pulse ratio (PPR).
Neurons were held at -80 mV in the presence of picrotoxin, and 2 presynaptic pulses
were applied with an inter-stimulation interval of 250 ms (4.0 Hz). The peak of the
second EPSC was then divided by the peak of the first EPSC (P2/P1) for quantification of
the PPR.
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Figure 20

Figure 20. Summary of experimental design as described in aim 2. Arrows represent
microinfusions 15 minutes before or immediately after behavioral testing. CPP,
conditioned place preference; sEPSC, spontaneous excitatory postsynaptic current.
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Figure 21

Figure 21. Focal stimulation induces monosynaptic, glutamate receptor-specific
postsynaptic currents in mPFC neurons. (A) Photomicrographs of biocytin-filled mPFC
pyramidal and GABAergic neurons. Scale bar represents 100 µm. (B) Example traces
of evoked EPSCs (50, 150, and 350 µA) in the presence of the GABAA antagonist
picrotoxin (100 µM) and AMPAr antagonist DNQX (10µM). (C) Evoked EPSCs were
larger in mPFC pyramidal neurons (n = 15) as compared with GABAergic interneurons
(n = 5). (D-F) Evoked EPSCs were glutamatergic, as application of the selective
GluN2B-containing NMDAr antagonist ifenprodil (3 µM) and nonselective NMDAr
antagonist APV (25 µM) abolished the EPSCs (Otis et al., 2014b). **p < 0.01 compared
with baseline. ^ p < 0.01 compared with ifenprodil-treated neurons.
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Results
Aim 1
The effects of PL-mFPC β-AR blockade on retrieval and subsequent
reinstatement of 1) contextual fear memories, 2) delay fear memories, and 3) trace fear
memories was first investigated.

Context fear conditioning
The necessity of PL-mPFC β-AR activation for recent contextual fear memory
retrieval was first examined. One day following contextual fear conditioning, rats were
given daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 6) or
nadolol (n = 4) before the first test only. Nadolol reduced freezing during the first test (t8
= 2.65, p = 0.03; Figure 22a-c), but not during subsequent nadolol-free tests (all t-values
< 1, all p-values > 0.05). Thus, PL-mPFC β-AR activation is required for fear expression
during a recent context fear memory retrieval test, but disruption of this activity does not
induce persistent fear memory impairments.
Next, the requirement of PL-mPFC β-AR activation for remote contextual fear
memory retrieval was assessed. Thirty-one days following contextual fear conditioning,
rats were given daily memory retrieval tests with PL-mPFC microinfusions of saline (n =
6) or nadolol (n = 7) before the first test only. Nadolol reduced freezing during the first
test (t11 = 2.35, p = 0.04; Figure 22d-f), but not during subsequent nadolol-free tests (all tvalues < 1, all p-values > 0.05). Thus, PL-mPFC β-AR activation is required for fear
expression during recent and remote context fear memory retrieval tests, but disruption of
this activity does not induce persistent fear memory impairments.
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Figure 22
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Figure 22. PL-mPFC β-AR blockade prevents retrieval of recent and remote
contextual fear memories. (a) PL-mPFC microinfusions of nadolol before a recent
context retrieval test (day 1) reduced freezing, but did not have any persistent effects on
freezing during subsequent drug-free tests. (b) PL-mPFC microinfusions of nadolol
before a remote context retrieval test (day 31) reduced freezing, but did not have
persistent effects on freezing during subsequent drug-free tests. *p < 0.05.
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Delay fear conditioning
The involvement of PL-mPFC β-AR activation for recent delay fear memory
retrieval was investigated. One day following delay fear conditioning, rats were given
daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 7) or nadolol (n
= 8) before the first test only. Nadolol prevented recent fear memory expression, but did
not have long-lasting effects on fear expression. During the first test, nadolol did not
significantly reduce freezing during the baseline period (t13 = 1.60, p = 0.13) or post CS
period (t13 = 2.08, p < 0.06; Figure 23a-c). However, nadolol reduced freezing during
presentation of the CS (t13 = 3.23, p = 0.007), indicating that recent delay fear memory
expression was reduced. In contrast, nadolol had no effect on freezing during subsequent
nadolol-free tests (all t-values < 1.3, all p-values > 0.05). Thus, PL-mPFC β-AR
activation is required for fear expression during a recent delay fear memory retrieval test,
but disruption of this activity does not induce persistent fear memory impairments.
Next, the requirement of PL-mPFC β-AR activation for remote delay fear
memory retrieval was assessed. Thirty-one days following delay fear conditioning, rats
were given daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 10)
or nadolol (n = 8) before the first test only. Nadolol had no effect on freezing during the
first test or during subsequent nadolol-free tests (all t-values < 2.0, all p-values > 0.05;
Figure 23d-f). Thus, β-AR activation is necessary for fear expression during a recent, but
not remote, delay fear memory retrieval test
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Figure 23
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Figure 23. PL-mPFC β-AR blockade prevents retrieval of recent but not remote
delay fear memories. (a-c) PL-mPFC microinfusions of nadolol before a recent delay
fear memory retrieval test (day 1) reduced freezing during CS presentation, but did not
have persistent effects on freezing during subsequent drug-free tests. (d-f) PL-mPFC
microinfusions of nadolol before a remote delay fear memory retrieval test (day 31) did
not reduce freezing during that test or during subsequent drug-free tests. **p < 0.01.
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Trace fear conditioning
The involvement of PL-mPFC β-AR activation for recent trace fear memory
retrieval was investigated. One day following trace fear conditioning, rats were given
daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 5) or nadolol (n
= 5) before the first test only. Nadolol had no effect on freezing during the first test or
during subsequent nadolol-free tests (all t-values < 2.0, all p-values > 0.05; Figure 24a-c).
Thus, β-AR activation is not required for fear expression during a recent trace fear
memory retrieval test.
Next, the requirement of PL-mPFC β-AR activation for remote trace fear memory
retrieval was assessed. Thirty-one days following trace fear conditioning, rats were given
daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 5) or nadolol (n
= 4) before the first test only. Nadolol prevented trace fear memory expression during
this test and during a subsequent UCS-induced reinstatement test (Figure 24d-f). During
the first test, nadolol had no effect on freezing during the baseline period (t8 = 0.92, p =
0.39). However, nadolol reduced freezing during presentation of the CS (t8 = 3.52, p =
0.01) and during the post-CS period (t8 = 11.32, p = 0.000009), indicating nadolol
reduced remote trace fear memory expression. In contrast, nadolol had no effect on
freezing during the next nadolol-free test or during the final nadolol-free extinction test
(all t-values < 1.3, all p-values > 0.05). During the nadolol-free reinstatement test,
however, previous nadolol treatment significantly reduced freezing during the baseline
period (t8 = 3.52, p = 0.01) and during the post CS period (t8 = 3.18, p = 0.02). However,
freezing during presentation of the CS was not significantly reduced (t8 = 3.52, p = 0.01).
Taken together, β-AR activation is necessary for fear expression during a remote, but not
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recent, trace fear memory retrieval test. Moreover, disruption of β-AR activity during
remote trace fear memory retrieval prevents subsequent reinstatement of the memory.
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Figure 24. PL-mPFC β-AR blockade prevents retrieval and subsequent
reinstatement of remote trace fear memory. (a-c) PL-mPFC microinfusions of
nadolol before a recent trace fear retrieval test (day 1) did not reduce freezing during that
test or during subsequent drug-free tests (d-f) PL-mPFC microinfusions of nadolol before
a remote trace fear memory retrieval test (day 31) reduced freezing during that test and
during a subsequent UCS-induced reinstatement. *p < 0.05, **p < 0.01, *****p <
0.00001.
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Aim 2
The mechanisms of cocaine-associated memory retrieval impairments were next
investigated. Following conditioning, rats were given two daily CPP tests, with systemic
injections of saline (n = 15) or propranolol (n = 6; 10 mg/kg) before the first test only.
Similar to previous investigations, propranolol prevented CPP expression during the CPP
test and during a subsequent propranolol-free CPP test (Figure 21a). Repeated measures
ANOVA revealed an effect of group (F1,19 = 11.74, p = 0.003), and post-hoc comparisons
revealed that CPP-S rats had significantly higher CPP scores as compared with CPP-P
rats during the first and second CPP tests (ps < 0.01). Thus, propranolol persistently
impaired retrieval of the cocaine-induced CPP memory, consistent with previous findings
(Otis and Mueller, 2011; Otis et al., 2013).

Intrinsic excitability (-70 mV)
β-AR blockade before the first CPP test induced a CPP memory retrieval
impairment, but whether CPP conditioning or β-AR blockade modifies the intrinsic
excitability of PL-mPFC neurons is unknown. Thus, one hour following the second CPP
test, rats were sacrificed and electrophysiological recordings were obtained from PLmPFC neurons held at a voltage of -70 mV. We found subtle potentiation in the
excitability of PL-mPFC neurons after CPP conditioning, and this enhancement was not
modified by propranolol treatment (Figure 26a-d). First, no differences in the number of
evoked action potentials were found overall in neurons taken from naïve (n = 14), CPP-S
(n = 36), and CPP-P rats (n = 23). ANOVA revealed no input by group interaction
(F20,700 = 1.23, p = 0.22), suggesting that the number of evoked action potentials were
similar across groups. Despite this, further analysis revealed that the excitability slope
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(rising slope of spikes by level of somatic depolarization) for CPP-S and CPP-P may
have increased following CPP conditioning. One-way ANOVA revealed a trend between
groups (F2,70 = 2.70, p = 0.07), and post-hoc analysis revealed that neurons from CPP-S
and CPP-P rats had a significantly higher excitability slopes as compared with neurons
from naïve rats (ps < 0.05). In contrast, no differences were found between CPP-S and
CPP-P rats (p = 0.65). Furthermore, no overall differences between groups were found
for the maximum number of evoked spikes (one-way ANOVA: F2,70 = 2.04, p = 0.14),
although direct comparison between neurons taken from naïve and both CPP-s and CPPP rats revealed an increase in the maximum number of spikes for PL-mPFC neurons
following CPP conditioning (Figure 22d, t71 =2.04, p <0.05). These data indicate that
CPP conditioning may induce a subtle potentiation in the excitability of PL-mPFC
pyramidal neurons.
We next examined whether the excitability of PL-mPFC pyramidal neurons
changed in all rats, or specifically in rats showing CPP memory retrieval. Rats were split
into groups expressing CPP scores below the mean (< 335 seconds, N = 3) versus those
expressing CPP scores above the mean (>335 seconds, N = 8). Rats with CPP scores
above the mean (high retrieval, HR) had significantly elevated CPP scores as compared
with rats expressing CPP scores below the mean (low retrieval, LR; Figure 26e).
Repeated measures ANOVA revealed a between groups effect (F1,9 = 6.34, p = 0.03), and
post-hoc analyses confirmed a significant increase in CPP for HR rats as compared to LR
rats during the second CPP test (p = 0.0005), although no significant difference during
the first test (p = 0.24). Thus, HR rats expressed higher CPP scores as compared to LR
rats. Next, we analyzed the excitability of PL-mPFC neurons from these rats while
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holding the neurons at -70 mV. PL-mPFC pyramidal neurons from HR rats (n = 22) had
increased excitability as compared with those from both LR rats (n = 14) and naïve rats (n
= 14; Figure 26f-h). Repeated-measures ANOVA indicated an input by group interaction
for the number of evoked spikes (F20,470 = 3.54, p = 0.000001), revealing that the
excitability of PL-mPFC neurons was different between groups. One-way ANOVA
further confirmed that excitability slope was different between groups (F2,47 = 8.07, p <
0.001) and maximum spikes was different between groups (F2,47 = 8.33, p < 0.001).
Finally, post-hoc analysis revealed that neurons from HR rats had significantly higher
excitability slope (ps < 0.003) and maximum spikes (ps = 0.001) as compared with
neurons from naïve and LR rats. These data reveal that the intrinsic neuronal excitability
of PL-mPFC pyramidal neurons is increased in rats expressing high CPP memory
retrieval, but not in rats expressing low CPP memory retrieval.
We also found that CPP memory retrieval positively correlated with intrinsic
neuronal excitability (Figure 27). CPP scores from CPP-S rats correlated with
excitability slope (r9 = 0.73, p = 0.01) and maximum spikes (r9 = 0.77, p = 0.006) when
neurons were held at -70 mV. In contrast, CPP scores from CPP-P rats did not correlate
with excitability slope (r4 = -0.61, p = 0.20) or maximum spikes (r4 = -0.66, p = 0.16)
when neurons were held at -70 mV. Taken together, these data indicate that enhancement
of PL-mPFC neuronal excitability supports CPP memory retrieval. Furthermore,
inhibition of PL-mPFC β-AR activation, which limits PL-mPFC excitability (Otis et al.,
2013), may prevent PL-mPFC neuronal excitability from supporting memory retrieval.

Figure 1
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Figure 25. β-AR blockade persistently impairs expression of a cocaine CPP
memory. Systemic injections of propranolol, but not saline, before the first CPP test
prevented rats from expressing a cocaine CPP during the first test and during a
subsequent propranolol-free test (similar to previous observations by Otis and Mueller,
2011). **p < 0.01.
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Figure 26
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Figure 26. Cocaine conditioning increases the excitability of PL-mPFC pyramidal
neurons (held at -70 mV) in rats expressing robust CPP memory retrieval. (a)
Example waveforms revealing the number of action potentials evoked following somatic
depolarization of PL-mPFC pyramidal neurons. (b) The number of evoked spikes was
unchanged overall between naïve, CPP-S, and CPP-P rats. (c, d) The excitability slope
and maximum number of spikes was increased in rats that underwent CPP conditioning.
(e) Rats were split into groups expressing low and high retrieval. (f-h) The number of
evoked spikes, excitability slope, and maximum spikes was increased in neurons taken
from HR rats versus LR and naïve rats. LR, low retrieval; HR, high retrieval. *p < 0.05,
***p < 0.001.

Figure 3

88

Figure 27
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Figure 27. Excitability of PL-mPFC pyramidal neurons (held at -70 mV) positively
correlates with CPP memory retrieval. (a, d) Overall, CPP scores from CPP-S and
CPP-P rats do not correlate with excitability slope or maximum spikes of PL-mPFC
neurons. (b, e) CPP scores from CPP-S rats positively correlate with excitability and
maximum spikes of PL-mPFC neurons. (c, f) CPP scores from CPP-P rats do not
positively correlate with excitability slope or maximum spikes of PL-mPFC neurons.
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Intrinsic excitability (resting membrane potential)
Differences in PL-mPFC resting membrane potential could contribute to the
cocaine conditioning-induced modifications in PL-mPFC intrinsic neuronal excitability.
To assess this, we replicated excitability recordings in neurons held at resting membrane
potential. These recordings yielded an identical pattern of results, indicating that CPP
conditioning increases PL-mPFC neuronal excitability without modifying resting
membrane potential (Figure 28).
Similar to recordings at -70 mV, no differences were found for the number of
evoked action potentials in neurons taken from naïve (n = 15), CPP-S (n = 39), and CPPP rats (n = 24; Figure 28a). ANOVA revealed no input by group interaction (F20,750 =
1.23, p = 0.22), suggesting that the number of evoked action potentials were similar
across groups. Despite this, further analysis revealed that the excitability slope for
neurons taken from CPP-S and CPP-P rats may have increased following conditioning
(Figure 28b). One-way ANOVA revealed a trend between groups (F2,75 = 2.94, p = 0.06),
and post-hoc analysis revealed that neurons from CPP-S and CPP-P rats had a trend
toward higher excitability slopes as compared with neurons from naïve rats (ps < 0.07).
Furthermore, direct comparison between naïve and cocaine-conditioned rats indicated
that neurons taken from cocaine-conditioned rats had increased excitability slope (t76 =
2.30, p = 0.02). No overall differences between groups were found for the maximum
number of spikes (one-way ANOVA: F2,75 = 2.33, p = 0.10), although direct comparison
between neurons taken from naïve and CPP rats revealed an increase in the maximum
number of spikes for PL-mPFC neurons following CPP conditioning (t76 = 2.06, p = 0.04;
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Figure 28c). These data provide further support that CPP conditioning increases the
excitability of PL-mPFC neurons.
We next examined whether the excitability of PL-mPFC pyramidal neurons held
at resting membrane potential was different in rats expressing high CPP memory retrieval
versus those expressing low CPP memory retrieval. PL-mPFC pyramidal neurons from
HR rats (n = 24) had increased excitability as compared with those from both LR rats (n
= 15) and naïve rats (n = 15; Figure 28d-f). Repeated-measures ANOVA indicated an
input by group interaction for the number of evoked spikes (F20,510 = 3.34, p = 0.000002),
revealing that the excitability of PL-mPFC neurons was different between groups. Oneway ANOVA further confirmed that excitability slope was different between groups
(F2,51 = 5.43, p = 0.007) and maximum spikes was different between groups (F2,51 = 5.27,
p = 0.008). Finally, post-hoc analysis revealed that neurons from HR rats had
significantly higher excitability slope and maximum spikes (ps = 0.003) as compared
with neurons from naïve rats. These data reveal that the intrinsic neuronal excitability of
PL-mPFC pyramidal neurons held at resting membrane potential is increased in rats
expressing high CPP memory retrieval, but not in rats expressing low CPP memory
retrieval.
We also found that CPP memory retrieval positively correlated with intrinsic
neuronal excitability when neurons were held at resting membrane potential (Figure 29).
CPP scores from CPP-S rats correlated with excitability slope (r9 = 0.66, p = 0.03) and
maximum spikes (r9 = 0.74, p = 0.01) when neurons were held at resting membrane
potential. In contrast, CPP scores from CPP-P rats did not significantly correlate with
excitability slope (r4 = -0.52, p = 0.29) or maximum spikes (r4 = -0.73, p = 0.10) when
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neurons were held at resting membrane potential. Taken together, these data indicate that
enhancement of PL-mPFC neuronal excitability supports CPP memory retrieval, and
changes in resting membrane potential do not ameliorate this effect. Despite this, how βAR activity maintains CPP memory retrieval remains to be determined.
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Figure 4
Figure 28
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Figure 28. Cocaine conditioning increases the excitability of PL-mPFC pyramidal
neurons (held at resting membrane potential) in rats expressing robust CPP
memory retrieval. (a) The number of evoked spikes was unchanged overall between
naïve, CPP-S, and CPP-P rats. (b, c) The excitability slope and maximum number of
spikes was increased in rats that underwent CPP conditioning. (d-f) The number of
evoked spikes, excitability slope, and maximum spikes was increased in neurons taken
from HR rats versus LR and naïve rats. LR, low retrieval; HR, high retrieval. *p < 0.05,
***p < 0.001.
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Figure 29
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Figure 29. Excitability of PL-mPFC pyramidal neurons (held at resting membrane
potential) positively correlates with CPP memory retrieval. (a, d) Overall, CPP
scores from CPP-S and CPP-P rats do not correlate with excitability slope or maximum
spikes of PL-mPFC neurons. (b, e) CPP scores from CPP-S rats positively correlate with
excitability and maximum spikes of Pl-mPFC neurons. (c, f) CPP scores from CPP-P rats
do not positively correlate with excitability slope or maximum spikes of PL-mPFC
neurons.
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Synaptic plasticity
CPP conditioning increases the excitability of PL-mPFC pyramidal neurons, and
this excitability is associated with CPP memory retrieval. Despite this, how β-AR
activation maintains CPP memory retrieval remains unclear. Thus, we recorded sEPSCs
(-80 mV) from PL-mPFC neurons taken from naïve (n = 9), CPP-S (n = 27), and CPP-P
rats (n = 17). Next, sEPSC amplitude was analyzed as a measure of postsynaptic
plasticity, whereas sEPSC frequency was analyzed as a measure of presynaptic plasticity.
Data reveal that the sEPSC amplitude and frequency were increased in cocaineconditioned rats, and propranolol reversed this change (Figure 30). One-way ANOVA
revealed a significant effect of group for sEPSC amplitudes (F2,50 = 12.65, p = 0.00004),
and post-hoc analyses confirmed an increase sEPSC amplitude for neurons from CPP-S
rats as compared with naïve and CPP-P rats (ps < 0.004). Similarly, one-way ANOVA
revealed a significant effect of group for sEPSC frequency (F2,50 = 5.37, p = 0.008), and
post-hoc analyses confirmed an increase in sEPSC frequency for neurons from CPP-S
rats as compared with naïve and CPP-P rats (ps < 0.03). Thus, CPP conditioning
increased the amplitude and frequency of sEPSCs in PL-mPFC pyramidal neurons,
indicating postsynaptic and presynaptic potentiation, respectively. Moreover, β-AR
blockade during memory retrieval reversed this plasticity.
The changes in sEPSC amplitude indicate postsynaptic modifications, possibly
due to potentiation of AMPAr currents. To investigate this, AMPA:NMDA ratios were
recorded. EPSCs were evoked at -80 mV (AMPAr currents) and -35 mV (NMDAr
currents) in PL-mPFC neurons taken from naïve (n = 7), CPP-S (n = 16), and CPP-P rats
(n = 12). Data reveal an increase in AMPA:NMDA ratio in neurons taken from cocaine-
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conditioned rats, and propranolol reversed this plasticity (Figure 31a,b). One-way
ANOVA revealed a significant effect of group (F2,32 = 16.39, p = 0.00001), and post-hoc
analyses confirmed an increase AMPA:NMDA ratio in neurons taken from CPP-S rats as
compared with naïve and CPP-P rats (ps < 0.001). Thus, CPP conditioning increased the
AMPA:NMDA ratio, and this increase was reversed by propranolol. We confirmed these
findings by re-calculating the AMPA:NMDA ratio by applying APV, the NMDAr
antagonist, in neurons taken from naïve (n = 3), CPP-S (n = 5), and CPP-P rats (n = 3).
Similar to the above findings, cocaine conditioning increased the AMPA:NMDA ratio,
and this increase was reversed by propranolol injections before the first memory retrieval
test (Figure 32a-b). One-way ANOVA revealed an effect of group (F2,8 = 5.08, p = 0.04),
and post-hoc analyses confirmed an increase in AMPA:NMDA ratio for neurons taken
from CPP-S rats as compared with naïve and CPP-P rats (ps < 0.05). Moreover,
AMPA:NMDA ratios measured by voltage were positively correlated with those
measured by APV in the same PL-mPFC neurons (r9 = 0.92, p < 0.00001). Thus, CPP
conditioning increased the AMPA:NMDA ratio, as measured using voltage clamp or
APV, and this effect was reversed by propranolol. These findings indicate a long-term
enhancement in AMPAr currents following cocaine CPP conditioning, and this synaptic
plasticity is reversed by β-AR blockade during CPP memory retrieval.
Along with postsynaptic plasticity, the sEPSC frequency was increased in PLmPFC neurons from cocaine-conditioned rats, indicating presynaptic plasticity. To
further investigate this we recorded the PPR, a second marker of presynaptic plasticity, in
neurons taken from naïve (n = 7), CPP-S (n = 18), and CPP-P (n = 17) rats. Cocaine
conditioning increased the PPR in PL-mPFC neurons, an effect that was reversed by
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propranolol (Figure 31c,d). One-way ANOVA revealed a significant effect of group
(F2,39 = 9.62, p = 0.00004), and post-hoc analyses confirmed an increased PPR for
neurons taken from CPP-S rats as compared with naïve and CPP-P rats (ps < 0.003).
Thus, CPP conditioning induced paired-pulse facilitation in PL-mPFC neurons,
indicating presynaptic potentiation. Moreover, this presynaptic plasticity was reversed by
propranolol.

97

Figure 30

Figure 30. β-AR blockade during memory retrieval reverses cocaine conditioninginduced potentiation of PL-mPFC sEPSCs. (a) Example waveforms of PL-mPFC
sEPSCs from PL-mPFC pyramidal neurons. Scale bars represent 50 pA (vertical) and
100 ms (horizontal). (b) Cumulative frequency distribution and means plot reveal an
increase in the amplitude of sEPSCs in neurons from CPP-S rats versus CPP-P and naïve
rats. (c) Cumulative frequency distribution reveals a decrease in the sEPSC inter-event
interval, and the means plot confirms that the frequency of sEPSCs increased in neurons
taken from CPP-S versus CPP-P and naïve rats. **p < 0.01.
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Figure 31

Figure 31. β-AR blockade reverses cocaine conditioning-induced AMPAr
potentiation and paired-pulse facilitation in PL-mPFC neurons. (a) Example
waveforms of evoked EPSCs at -80 mV (blue traces, AMPAr EPSCs) and -35 mV (red
traces, NMDAr EPSCs) that were used to quantify AMPA:NMDA ratios. (b)
AMPA:NMDA ratios were increased in neurons from CPP-S rats versus CPP-P and naïve
rats. (c) Example waveforms revealing PPRs (P2/P1) in PL-mPFC neurons. (d) PPRs
were increased in neurons from CPP-S rats versus CPP-P and naïve rats. Scale bars
represent 50 pA (vertical) and 100 ms (horizontal). P2/P1, pulse 2 divided by pulse 1
**p < 0.01, ***p < 0.001.
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Figure 32

Figure 32. Confirmation that β-AR blockade reverses cocaine conditioning-induced
AMPAr potentiation in PL-mPFC neurons. (a) Example waveforms of evoked EPSCs
at -35 mV after APV application (blue, AMPAr EPSCs) and the calculated difference
(red, NMDAr EPSCs). (b) AMPA:NMDA ratios recorded via APV application were
increased in neurons from CPP-S rats versus CPP-P and naïve rats. (c) AMPA:NMDA
ratios as recorded by voltage clamp positively correlate with AMPA:NMDA ratios
recorded by APV application in the same PL-mPFC neurons.
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Data reveal presynaptic and postsynaptic plasticity in PL-mPFC neurons
following cocaine conditioning. Moreover, this plasticity is reversed by β-AR blockade
during memory retrieval. Next we confirmed that this reversal was specific to β-AR
blockade during CPP memory retrieval, and not due to nonspecific effects such as
reconsolidation blockade. Following conditioning, rats were given two daily CPP tests
with systemic injections of propranolol after the first test only (N = 5, CPP-PP, Figure
33a). One hour after the second test, rats were sacrificed for patch clamp
electrophysiology. Overall, data reveal that posttest injections of propranolol did not
reverse the increase in PL-mPFC synaptic potentiation (Figure 33b-h). First, sEPSC
amplitudes were increased in neurons taken from CPP-PP rats (n = 5) as compared with
neurons taken from naïve rats (n = 9; t12 = 3.12, p = 0.009). Similarly, sEPSCs were
more frequent in neurons taken from CPP-PP rats (n = 5) as compared with those from
naïve rats (n = 9; t12 = 2.95, p = 0.01). These indicate that propranolol has no effect on
presynaptic and postsynaptic plasticity in PL-mPFC when given after memory retrieval.
In further support of this, neurons taken from CPP-PP rats (n = 5) had increased
AMPA:NMDA ratio (as measured by voltage) as compared with neurons taken from
naïve rats (n = 7; t10 = 2.19, p = 0.05). Finally, the PPR was increased in neurons taken
from CPP-PP rats (n = 7) as compared with neurons taken from naïve rats (n = 7; t12 =
3.78, p = 0.003). Taken together, β-AR blockade after CPP memory retrieval did not
reverse the change in sEPSC amplitude, sEPSC frequency, AMPA:NMDA ratio, or PPR.
Thus, these data confirm that β-AR activation during memory retrieval, but not after,
maintains cocaine-related plasticity in PL-mPFC pyramidal neurons.
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Figure 33

Figure 33. Post-retrieval propranolol does not reverse cocaine conditioning-induced
presynaptic and postsynaptic plasticity in PL-mPFC neurons. (a) Post-test
propranolol injections did not prevent CPP expression during a subsequent propranololfree test. (b-d) sEPSC frequency and amplitude were increased in PL-mPFC neurons
from CPP-PP rats versus naïve rats. (e,f) AMPA:NMDA ratios as measured by voltage
clamp were increased in PL-mPFC neurons from CPP-PP rats versus naïve rats. (g,h)
PPRs were increased in PL-mPFC neurons from CPP-PP rats versus naïve rats. *p <
0.05, **p < 0.01.
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Discussion
This dissertation aims (1) to establish whether PL-mPFC β-AR activation is a
fundamental mechanism for maintenance of memory retrieval and (2) to determine the
mechanism of cocaine-associated memory retrieval impairments.
Results reveal that PL-mPFC β-AR activation is not a fundamental mechanism
required for maintenance of fear memory retrieval. PL-mPFC infusions of the β-AR
antagonist nadolol reduced fear during context, recent delay, and remote trace fear
memory retrieval tests, but had no effect during a subsequent retrieval test. However,
PL-mPFC β-AR blockade during the remote trace fear memory retrieval test reduced
subsequent reinstatement, indicating some long-lasting effects of β-AR blockade on the
fear memory. Next, results reveal the mechanism of cocaine-associated memory retrieval
impairments. Cocaine conditioning increased intrinsic neuronal excitability of PL-mPFC
neurons, particularly in rats expressing high CPP memory retrieval. Further, cocaine
conditioning induced presynaptic and postsynaptic potentiation in PL-mPFC neurons.
Finally, systemic injections of the β-AR antagonist propranolol during, but not after
retrieval, reversed the synaptic plasticity in PL-mPFC neurons. Taken together, reversal
of PL-mPFC synaptic potentiation by β-AR blockade induces long-lasting cocaineassociated memory retrieval impairments, but not long-lasting fear memory retrieval
impairments.

Aim 1
Data reveal that PL-mPFC β-AR blockade reduced fear during recent and remote
contextual fear memory retrieval tests. These findings are consistent with data revealing
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PL-mPFC inactivation reduces contextual fear memory expression 24h after conditioning
(Corcoran and Quirk, 2007; Laurent and Westbrook, 2009). Similarly, PL-mPFC lesions
prevent context-dependent cued fear expression 8d after conditioning (Kim et al., 2013),
supporting the idea that PL-mPFC regulates both recent and remote contextual fear
memories. Unit recording data further reveal that PL-mPFC neurons exhibit contextdependent short-latency responses to a fear-conditioned cue (Kim et al., 2013). Taken
together, PL-mPFC neurons may encode contextual information for fear expression. Our
data further reveal that PL-mPFC β-AR activation promotes neural activity in PL-mPFC
neurons for expression of recent and remote contextual fear memories.
PL-mPFC β-AR blockade reduced fear expression during a recent delay fear
memory retrieval test, but not during a remote delay fear memory retrieval test.
Inactivation of PL-mPFC also reduces recent delay fear memory expression (Corcoran
and Quirk, 2007; Sierra-Mercado et al., 2011). In contrast, microstimulation of PLmPFC increases fear expression when a delay fear conditioned cue is presented, whereas
PL-mPFC microstimulation alone does not induce fear (Vidal-Gonzalez et al., 2006).
Finally, PL-mPFC, neurons exhibit sustained tone responses during presentation of a
recently fear-conditioned cue, and this firing correlates with delay fear expression
(Burgos-Robles et al., 2009). Thus, these data are consistent with the idea that β-AR
signaling in PL-mPFC neurons support the neural activity required for recent delay fear
memory retrieval.
PL-mPFC β-AR blockade reduced fear expression during a remote trace fear
memory retrieval test, but not during a recent trace fear memory retrieval test. Although
much evidence supports the involvement of PL-mPFC for trace fear conditioning (Baeg
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et al., 2001; Gilmartin and McEchron, 2005; Gilmartin and Helmstetter, 2010; Guimarais
et al., 2011; Gilmartin et al., 2013), only one recent study has examined the necessity of
PL-mPFC for expression of a recent and remote trace fear memories. Beeman and
colleagues (2013) found that lesions made 30d following conditioning reduces freezing
during a remote trace fear memory retrieval test. In contrast, lesions made 1d following
conditioning had no effect on freezing during a recent trace fear memory retrieval test
(Beeman et al., 2013). Overall, these data support the conclusion that PL-mPFC β-AR
signaling is required for remote trace fear memory retrieval, but not recent trace fear
memory retrieval. The mechanism by which this PL-mPFC β-AR activation allows
subsequent reinstatement of the trace fear memory, however, is unclear.
Results reveal that fear memory retrieval is not susceptible to memory retrieval
impairments by PL-mPFC β-AR blockade. However, unpublished data from several labs
indicate that fear memories are susceptible to memory retrieval impairments. For
example, oral administration of a β-AR antagonist persistently reduces cue-induced fear
expression and subsequent reinstatement in humans (Kroes et al, 2012 SfN Abstracts).
Furthermore, pharmacological or optogenetic inactivation of paraventricular thalamic
neurons reduces delay fear memory retrieval in rodents during a retrieval test and during
a subsequent manipulation-free test (Do-Monte et al, 2013 SfN Abstracts). Taken
together, fear memories can be persistently impaired during retrieval. Despite this, future
experiments need to be performed to determine the particular mechanisms that maintain
fear memory retrieval.

105

Aim 2
Experiments described in aim 2 reveal the mechanism of memory retrieval
impairments. Cocaine conditioning increased the intrinsic excitability of PL-mPFC
pyramidal neurons, particularly in rats expressing high CPP memory retrieval.
Furthermore, cocaine conditioning increased sEPSC frequency and induced paired-pulse
facilitation in PL-mPFC pyramidal neurons, indicative of presynaptic potentiation.
Cocaine conditioning also increased sEPSC amplitude and AMPA:NMDA ratios,
indicative of postsynaptic potentiation. Finally, β-AR blockade during but not after a
CPP test induced persistent impairments in CPP memory retrieval and reversed
modifications in sEPSC frequency, sEPSC amplitude, PPR, and AMPA:NMDA ratios.
In contrast, β-AR blockade during memory retrieval did not reverse modifications in
intrinsic neuronal excitability. Taken together, CPP memory retrieval impairments are
likely due to reversal of cocaine-related synaptic potentiation in PL-mPFC pyramidal
neurons.

Intrinsic plasticity
Cocaine conditioning increased the excitability of PL-mPFC pyramidal neurons in
rats expressing high CPP memory retrieval but not low CPP memory retrieval.
Furthermore, PL-mPFC neuronal excitability positively correlated with CPP expression,
unless the β-AR antagonist propranolol was administered during memory retrieval.
These data are consistent with previous observations that cocaine increases the
excitability of neurons in mPFC. Repeated systemic administration of cocaine decreases
conductance of voltage-gated K+ channels (mainly slowly inactivating (ID) K+ channels),
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resulting in enhanced membrane excitability (Dong et al., 2005; Nasif et al., 2005b).
Furthermore, repeated cocaine increases voltage-gated Ca2+ currents (IC) via enhanced
conductance of high-voltage activated (HVA) L-type Ca2+ channels (Nasif et al., 2005a;
Ford et al., 2009). Unlike other HVA Ca2+ channels that control medium and slowafterhyperpolarization, HVA L-type Ca2+ channels promote repetitive firing by reducing
the interspike interval of neocortical pyramidal neurons (Pineda et al., 1998). Thus,
enhanced L-type Ca2+ currents may contribute to the enhancement of PL-mPFC
pyramidal neuron excitability following repeated cocaine exposure, particularly at high
voltages which induces repetitive firing of these neurons. To assess this, future analysis
should be completed to assess the interspike interval of PL-mPFC neurons in cocaineconditioned rats versus naïve rats. If HVA L-type Ca2+ channels contribute to cocaineinduced enhancement of PL-mPFC neuronal excitability, the interspike interval of these
neurons should be reduced in neurons from high retrieval rats but not low retrieval rats.

Synaptic plasticity
Cocaine conditioning induced presynaptic and postsynaptic potentiation in PLmPFC pyramidal neurons. These data are consistent with investigations characterizing
dendritic morphology of these neurons following exposure to psychostimulants.
Systemic injections of amphetamine and cocaine, for example, increase dendritic length,
dendritic branching, and dendritic spine density in dorsal mPFC pyramidal neurons for at
least one month (Robinson and Kolb, 1997, 1999). Similarly, cocaine self-administration
increased dendritic branching and dendritic spine density in dorsal mPFC pyramidal
neurons (Robinson et al., 2001). These findings paralleled dendritic spine plasticity in
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NAc medium spiny neurons (Robinson and Kolb, 1997, 1999; Robinson et al., 2001),
which receive input from PL-mPFC neurons for expression of drug seeking (McFarland
et al., 2003; Peters et al., 2009). Thus, long-lasting neuroadaptations within this
corticolimbic circuit may mediate drug-associated memory retrieval for the persistence of
drug seeking
Recent experiments using 2-photon microscopy in vivo confirm an increase in PLmPFC dendritic spine gain, and reveal no change in dendritic spine loss, in layer V dorsal
mPFC pyramidal neurons 2h and 96h following cocaine exposure (Munoz-Cuevas et al.,
2013). Moreover, these experiments reveal that PL-mPFC dendritic spine gain positively
correlates cocaine CPP expression. Thus, dendritic spine plasticity within layer V PLmPFC pyramidal neurons is a likely mechanism for cocaine-associated memory retrieval.
Data described here support this idea, revealing that cocaine conditioning induces both
presynaptic and postsynaptic plasticity within layer V PL-mPFC pyramidal neurons.
Moreover, we found that β-AR blockade during CPP memory retrieval reversed this
plasticity and prevented drug-associated memory retrieval. Thus, dendritic/synaptic
potentiation in PL-mPFC may be essential for cue-induced drug seeking. The
mechanism by which β-AR blockade reverses this plasticity, however, is less clear.

Mechanism
β-AR blockade induced a persistent impairment in retrieval of a cocaine-induced
CPP memory. This retrieval impairment could be in part due to transient limitation of
PL-mPFC intrinsic neuronal excitability. Presentation of salient stimuli causes activation
of locus coeruleus noradrenergic neurons (Sterpenich et al., 2006) and provokes
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norepinephrine release (Cassens et al., 1980). Norepinephrine enhances the excitability
of PL-mPFC pyramidal neurons, and this excitation is blocked by β-AR inhibition (Otis
et al., 2013). Thus, β-AR blockade prevents norepinephrine-induced enhancement of PLmPFC neuronal excitability during memory retrieval (Rodriguez-Romaguera et al.,
2009), indicating that β-AR-dependent potentiation of intrinsic excitability may maintain
retrieval. In support of this, unpublished data from our lab reveal that PL-mPFC protein
kinase A (PKA)-induced inhibition of Ca2+-activated K+ channels maintains retrieval
(Fitzgerald et al, unpublished). This cascade is downstream of β-ARs, and is the
mechanism by which β-AR activation increases neuronal excitability (Foehring et al.,
1989; Mueller et al., 2008). Taken together, both CPP conditioning and cue-induced βAR activation increase PL-mPFC pyramidal neuron excitability, and this neuronal
excitation is required for CPP memory retrieval. Despite this, data here reveal that
excitability of PL-mPFC neurons remain increased after β-AR blockade during retrieval.
Thus, long-lasting cocaine CPP memory retrieval impairments are not due to long-lasting
reversal of PL-mPFC intrinsic neuronal excitability.
Cocaine CPP conditioning induced intrinsic neuronal plasticity in PL-mPFC
neurons, and this plasticity may function in unison with synaptic plasticity for the control
of cocaine CPP memory retrieval. Previous research reveals dendritic spine growth in
layer V PL-mPFC pyramidal following cocaine CPP conditioning, and this spine growth
correlates with CPP memory retrieval (Munoz-Cuevas et al., 2013). Taken together with
data shown here, PL-mPFC synaptic potentiation likely controls cocaine-associated
memory retrieval. In further support of this, memory retrieval impairments induced by βAR blockade were associated with reversal of synaptic potentiation in PL-mPFC. These
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data indicate that β-AR activation during memory retrieval is critical for maintenance of
retrieval-related synaptic plasticity. Despite this, the mechanism underlying reversal of
synaptic plasticity by β-AR blockade during retrieval is unclear.
The data described here are consistent with the hypothesis that β-AR activation
maintains cocaine-associated memory retrieval by synchronizing PL-mPFC synaptic
input with postsynaptic activation of PL-mPFC pyramidal neurons. Specifically, intrinsic
excitability of PL-mPFC neurons is increased during cocaine CPP memory retrieval,
indicating that PL-mPFC neurons are more responsive to excitatory inputs. In contrast,
presynaptic input in the absence of synchronous postsynaptic action potentials can induce
synaptic depression (Froemke and Dan, 2002; Froemke et al., 2005). Thus, PL-mPFC βAR activation may maintain synchronous presynaptic and postsynaptic activity during
retrieval, whereas disruption of this synchrony likely weakens PL-mPFC synapses.
Consistent with this hypothesis, NE prevents spike-timing dependent depression (STDD)
at cortical synapses (Salgado et al., 2012). Thus, β-AR blockade during retrieval may
induce PL-mPFC synaptic depression by causing neural asynchrony, resulting in longterm retrieval impairments.

Future Directions
Reversal of PL-mPFC synaptic potentiation underlies cocaine-associated memory
retrieval deficits, although the neural circuits underlying memory retrieval are not welldefined. To assess the neural circuits of memory retrieval, genetic approaches can be
used to tag and manipulate the retrieval circuit both in vivo and in vitro. For example, I
plan to use arc-tTA transgenic mice (similar to Liu et al., 2014) along with
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adenoantivirus transfections (AAV-Chr2-mCherry or AAV-eArchT-mCherry) to allow
region-specific, activity-dependent tagging of neurons. Considering that
channelrhodopsin or archaerhodopsin are inserted within the adenoantivirus, this
technology would allow 1) tagging of neurons that become active during memory
retrieval, 2) optogenetic manipulation of these neurons in vivo, and 3)
electrophysiological characterization of these neurons in vitro. Thus, using a
combination of behavioral, genetic, and electrophysiological approaches the neural
circuits required for fear and drug-associated memory retrieval can be well defined.
Evidence described here indicates that PL-mPFC layer V pyramidal neurons
regulate memory retrieval. However, activity of these neurons is not only influenced by
synaptic inputs to PL-mPFC, but also by PL-mPFC interneurons. For example,
convincing evidence from Cyril Herry’s lab now indicate that PL-mPFC parvalbuminpositive interneurons coordinate theta oscillations for the control of fear expression
(Courtin et al., 2014). Thus, monitoring the coordinated activity of many geneticallydefined neurons would allow us to define how different types of neurons coordinate
activity within particular brain regions for memory retrieval. Such experiments could be
conducted using 2-photon ultrasensitive fluorescent calcium imaging (GCaMP6.0; Chen
et al., 2013). Using this technique along with genetic labeling of particular neurons (e.g.,
parvalbumin versus somatostatin interneurons), the neuronal assemblies which coordinate
activity within a given brain region for memory retrieval could be determined.
Although PL-mPFC β-AR blockade does not persistently impair fear memory
retrieval, evidence indicates that fear memory retrieval is susceptible to persistent
disruption (Kroes et al, 2012 SfN Abstracts; Do-Monte et al, 2013 SfN Abstracts). Thus,
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future experiments should identify how fear memory retrieval is maintained. For
example, Do-Monte and colleagues (2013, SfN Abstracts) found that optogenetic
inhibition of pavaraventricular thalamic inputs to the central amygdala (PVT-CeA)
persistently reduces remote delay fear memory retrieval. However, the mechanism by
which the PVT-CeA pathway maintains retrieval is completely unknown. To solve this,
experiments using optogenetic and electrophysiological approaches should be conducted.
For example, fear memory retrieval impairments could be induced via optogenetic
inhibition of the PVT-CeA pathway in vivo. Next, intrinsic and synaptic recordings of
CeA neurons can be obtained in vitro, with EPSCs evoked via optogenetic stimulation of
the PVT-CeA pathway. Based on the findings presented here, synaptic depotentiation of
PVT-CeA synapses may account for fear memory retrieval impairments. Findings such
as these would confirm that reversal of memory-related synaptic plasticity can occur
during both fear memory retrieval and cocaine-associated memory retrieval.

Clinical Relevance
Presentation of drug-associated cues leads to cravings and relapse among addicts,
whereas presentation of trauma-related cues can provoke anxiety and fear in PTSD
patients. Disruption of fear or drug-associated memory retrieval would therefore
alleviate these disorders. Data described here reveal for the first time that memoryrelated synaptic plasticity is maintained by neuronal activity during retrieval. Although
future experiments should further elucidate the mechanisms and neural circuits that
maintain synaptic plasticity during retrieval, these data provide the framework for
development of therapies that could lead to elimination of cue-induced drug seeking and
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fear. Currently, exposure therapy involves the repeated, unreinforced presentation of
drug or fear-related cues, inducing retrieval and extinction learning. Although extinction
leads to inhibition of cue-induced behaviors, spontaneous recovery and reinstatement of
those behaviors is common. Data described here reveal that a more direct approach of
reversing memory-related synaptic plasticity during retrieval (i.e., during exposure
therapy) may be possible. Such effects would not only eliminate cue-induced behaviors,
but would also provide long-lasting protection against spontaneous recovery and
reinstatement. Taken together, our findings support the use of pharmacological adjuncts
to exposure therapy, such as β-AR antagonists, for persistent impairment of fear and
drug-associated memory retrieval.
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